Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Kinetics of viral load and antibody response in relation to COVID-19 severity
Yanqun Wang, … , Yimin Li, Jincun Zhao
Yanqun Wang, … , Yimin Li, Jincun Zhao
Published July 7, 2020
Citation Information: J Clin Invest. 2020;130(10):5235-5244. https://doi.org/10.1172/JCI138759.
View: Text | PDF
Research Article Infectious disease Virology Article has an altmetric score of 241

Kinetics of viral load and antibody response in relation to COVID-19 severity

  • Text
  • PDF
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution, cross-reactivity, and neutralization antibody response in patients with COVID-19. Two groups of patients with RT-PCR–confirmed COVID-19 were enrolled in this study: 12 severely ill patients in intensive care units who needed mechanical ventilation and 11 mildly ill patients in isolation wards. Serial clinical samples were collected for laboratory detection. Results showed that most of the severely ill patients had viral shedding in a variety of tissues for 20–40 days after onset of disease (8/12, 66.7%), while the majority of mildly ill patients had viral shedding restricted to the respiratory tract and had no detectable virus RNA 10 days after onset (9/11, 81.8%). Mildly ill patients showed significantly lower IgM response compared with that of the severe group. IgG responses were detected in most patients in both the severe and mild groups at 9 days after onset, and remained at a high level throughout the study. Antibodies cross-reactive to SARS-CoV and SARS-CoV-2 were detected in patients with COVID-19 but not in patients with MERS. High levels of neutralizing antibodies were induced after about 10 days after onset in both severely and mildly ill patients which were higher in the severe group. SARS-CoV-2 pseudotype neutralization test and focus reduction neutralization test with authentic virus showed consistent results. Sera from patients with COVID-19 inhibited SARS-CoV-2 entry. Sera from convalescent patients with SARS or Middle East respiratory syndrome (MERS) did not. Anti–SARS-CoV-2 S and N IgG levels exhibited a moderate correlation with neutralization titers in patients’ plasma. This study improves our understanding of immune response in humans after SARS-CoV-2 infection.

Authors

Yanqun Wang, Lu Zhang, Ling Sang, Feng Ye, Shicong Ruan, Bei Zhong, Tie Song, Abeer N. Alshukairi, Rongchang Chen, Zhaoyong Zhang, Mian Gan, Airu Zhu, Yongbo Huang, Ling Luo, Chris Ka Pun Mok, Manal M. Al Gethamy, Haitao Tan, Zhengtu Li, Xiaofang Huang, Fang Li, Jing Sun, Yanjun Zhang, Liyan Wen, Yuming Li, Zhao Chen, Zhen Zhuang, Jianfen Zhuo, Chunke Chen, Lijun Kuang, Junxiang Wang, Huibin Lv, Yongliang Jiang, Min Li, Yimin Lin, Ying Deng, Lan Tang, Jieling Liang, Jicheng Huang, Stanley Perlman, Nanshan Zhong, Jingxian Zhao, J.S. Malik Peiris, Yimin Li, Jincun Zhao

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 Total
Citations: 5 20 39 89 191 41 385
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (385)

Title and authors Publication Year
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles
Svenja Weiss, Hung-Mo Lin, Eric Acosta, Natalia L Komarova, Ping Chen, Dominik Wodarz, Ian Baine, Ralf Duerr, Ania Wajnberg, Adrian Gervais, Paul Bastard, Jean-Laurent Casanova, Suzanne A Arinsburg, Talia H. Swartz, Judith A. Aberg, Nicole M. Bouvier, Sean T. H. Liu, Raymond A. Alvarez, Benjamin K. Chen
Journal of Clinical Investigation 2025
Host factor PLAC8 is required for pancreas infection by SARS-CoV-2
Ibargüen-González L, Heller S, López-García D, Dietenberger H, Barth TF, Gallego P, Fernández-Cadenas I, Alzate-Piñol S, Crespí C, Mena-Guerrero JA, Cisneros-Barroso E, Ugalde AP, Bretones G, Steenblock C, Kleger A, DeDiego ML, Barceló C
Communications Medicine 2025
Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort
Nouanesengsy A, Semesi A, Quach K, Ivanochko D, Byrne W, Hwang M, La Neve MR, Leon-Ponte M, Litosh A, Wisener N, Adeli K, Campigotto A, Grunebaum E, McGeer A, Moraes TJ, Sepiashvili L, Upton J, Julien JP, Allen U
Microbiology Spectrum 2025
Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study
Taha AE, Amer I, Sharawy SE, Ghazy AA
Viruses 2025
High-level adenovirus-neutralizing antibodies plasma beneficial for adenovirus type 7 (Adv7) induced pediatric severe ARDS
Chen F, Dang R, Zhao M, Chen Y, Huang J, Zuo Y, Yang Y
Journal of Virus Eradication 2025
Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants
Wang Y, Yan A, Song D, Duan M, Dong C, Chen J, Jiang Z, Gao Y, Rao M, Feng J, Zhang Z, Qi R, Ma X, Liu H, Yu B, Wang Q, Zong M, Jiao J, Xing P, Pan R, Li D, Xiao J, Sun J, Li Y, Zhang L, Shen Z, Sun B, Zhao Y, Zhang L, Dai J, Zhao J, Wang L, Dou C, Liu Z, Zhao J
Nature Communications 2024
Viral shedding of SARS-CoV-2 in body fluids associated with sexual activity: a systematic review and meta-analysis.
Calvet GA, Kara E, Gonsalves L, Seuc AH, de Oliveira RVC, Thwin SS, Gomez Ponce de León R, Gámez MC, Peña GM, Pendás BVR, Alzugaray MG, Carballo GO, Cala DC, Guimarães PMQ, Bonet M, Taylor M, Thorson A, Kim C, Ali M, Broutet N
BMJ Open 2024
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study.
Kim JS, Sun Y, Balte P, Cushman M, Boyle R, Tracy RP, Styer LM, Bell TD, Anderson MR, Allen NB, Schreiner PJ, Bowler RP, Schwartz DA, Lee JS, Xanthakis V, Doyle MF, Regan EA, Make BJ, Kanaya AM, Wenzel SE, Coresh J, Isasi CR, Raffield LM, Elkind MSV, Howard VJ, Ortega VE, Woodruff P, Cole SA, Henderson JM, Mantis NJ, Parker MM, Demmer RT, Oelsner EC
Nature Communications 2024
Lesson Learned from Mass Antibody Rapid Diagnostic Used in the Early COVID-19 Pandemic in Indonesia Contributors
Indrati AR, Budiailmiawan L, Markus L, Johanis J, Logito V, Aryati
Medical Devices (Auckland, N.Z.) 2024
The dynamics and determinants of specific systemic and mucosal antibody responses to SARS-CoV-2 in three adult cohorts in the Ecuadorian Andes: a study protocol
Leon-Rojas JE, Veloz T, Teran J, Perez M, Arias-Erazo F, Villacis L, Velez J, Recalde R, Jiménez P, Martin M, Chis Ster I, Cooper P, Romero N
F1000Research 2024
The dynamics and determinants of specific systemic and mucosal antibody responses to SARS-CoV-2 in three adult cohorts in the Ecuadorian Andes: a study protocol.
Leon-Rojas JE, Veloz T, Teran J, Perez M, Arias-Erazo F, Villacis L, Velez J, Recalde R, Jiménez P, Martin M, Chis Ster I, Cooper P, Romero N
F1000Research 2024
Comparison of Neutralizing Activity between Vaccinated and Unvaccinated Hospitalized COVID-19 Patients Infected with Delta, Omicron BA.1, or Omicron BA.2 Variant.
Kim KJ, Park SJ, Yun SG, Kim SW, Nam MH, Shin EK, Chang EA, Park DW, Lee CK, Yoon YK, Cho Y
Microorganisms 2024
Relationship between the Viral Load in Patients with Different COVID-19 Severities and SARS-CoV-2 Variants.
Santos Coy-Arechavaleta A, Alvarado-Yaah JE, Uribe-Noguez LA, Guerra-Castillo FX, Santacruz-Tinoco CE, Ramón-Gallegos E, Muñoz-Medina JE, Fernandes-Matano L
Microorganisms 2024
Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital
Rinaldi I, Yulianti M, Yunihastuti E, Rajabto W, Irawan C, Sukrisman L, Rachman A, Mulansari NA, Lubis AM, Prasetyawaty F, Cahyanur R, Priantono D, Ahani AR, Muthalib A, Sudoyo A, Atmakusuma TD, Reksodiputro AH, Djoerban Z, Tambunan K, Winston K, Shufiyani YM, Wiyono L, Pratama S, Edina BC
Journal of Clinical Medicine 2024
Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers
Najimi N, Tajount L, Regragui Z, Remz C, Ait-Lhaj-Mhand R, Kadi C, Belayachi L, Seghrouchni F, Nadia dakka, El Hassani RA, Elharti E, Oumzil H, Bakri Y
International journal of immunopathology and pharmacology 2024
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection
Abril AG, Alejandre J, Mariscal A, Alserawan L, Rabella N, Roman E, Lopez-Contreras J, Navarro F, Serrano E, Nomdedeu JM, Vidal S
Scientific Reports 2024
T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess
Pena NM, Santana LC, Hunter JR, Blum VF, Vergara T, Gouvea C, Leal E, Bellei N, Schechter M, Diaz RS
BMC Infectious Diseases 2024
Vaccines for the Elderly and Vaccination Programs in Europe and the United States
Anastassopoulou C, Ferous S, Medić S, Siafakas N, Boufidou F, Gioula G, Tsakris A
Human vaccines 2024
A Paper-Based Multiplexed Serological Test to Monitor Immunity against SARS-COV-2 Using Machine Learning
Eryilmaz M, Goncharov A, Han GR, Joung HA, Ballard ZS, Ghosh R, Zhang Y, Di Carlo D, Ozcan A
ACS Nano 2024
Reduced seasonal coronavirus incidence in high‐risk population groups during the COVID‐19 pandemic
Heiskanen A, Galipeau Y, Little J, Langlois M, Cooper CL
Immunity, Inflammation and Disease 2024
Severe COVID-19 in HIV/Leishmania infantum coinfected patient: a successfully managed case report.
Farias PCS, Bezerra GSN, Neves PAF, Cabral LP, Júnior WLB, Guedes DL, Xavier AT, Medeiros ZM, Lorena VMB, Araújo PSR, de Queiroz Balbino V, de Lima Neto RG
BMC infectious diseases 2024
Defining the features and structure of neutralizing antibody targeting the silent face of the SARS‐CoV‐2 spike N‐terminal domain
Zhang Z, Zhang Y, Zhang Y, Cheng L, Zhang L, Yan Q, Liu X, Chen J, Dai J, Guo Y, Wei P, Xiong X, Xiao J, Zhu A, Zhuo J, Cai R, Zhang J, Rao H, Qu B, Zhang S, Feng J, Cheng J, Su J, Chen C, Li S, Zhang Y, Chen L, Jin Y, Xu Y, Liu X, Li Y, Zhao J, Wang Y, Zhou Q, Zhao J
MedComm 2024
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases
Leong RW, Sakiris A, Arzivian A, Chetwood JD, Chaemsupaphan T, Sparrow MP, Kamm MA, Kariayawasam V
Alimentary Pharmacology & Therapeutics 2024
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses
Bayarri-Olmos R, Sutta A, Rosbjerg A, Mortensen MM, Helgstrand C, Nielsen PF, Pérez-Alós L, González-García B, Johnsen LB, Matthiesen F, Egebjerg T, Hansen CB, Sette A, Grifoni A, Antunes RD, Garred P
Frontiers in Immunology 2024
Nanotechnology-Based Modern Biosensors for the Detection of SARS-CoV-2 Virus.
Devi S, Yadav N, Yadav R
Indian journal of microbiology 2024
Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination.
Wang M, Zhou B, Fan Q, Zhou X, Liao X, Lin J, Ma Z, Dong J, Wang H, Ge X, Ju B, Zhang Z
Emerging Microbes & Infections 2023
Correlation of ENT Symptoms with Age, Sex, and Anti-SARS-CoV-2 Antibody Titer in Plasma
Kwaśniewska A, Kwaśniewski K, Skorek A, Tretiakow D, Jaźwińska-Curyłło A, Burduk P
Journal of Clinical Medicine 2023
Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2.
Huang X, Liang C, Li M, Chen H, Li Z, Ruan Q, Hu X, Zeng L, Lin H, Zhao W, Xiao J, Sun L, Sun J
Human vaccines 2023
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
Miyamoto S, Arashiro T, Ueno A, Kanno T, Saito S, Katano H, Iida S, Ainai A, Ozono S, Hemmi T, Hirata Y, Moriyama S, Kotaki R, Kinoshita H, Yamada S, Shinkai M, Fukushi S, Takahashi Y, Suzuki T
iScience 2023
Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings
Benabdessalem C, Hamouda WB, Marzouki S, Faye R, Mbow AA, Diouf B, Ndiaye O, Dia N, Faye O, Sall AA, Diagne CT, Amellal H, Ezzikouri S, Mioramalala DJ, Randrianarisaona F, Trabelsi K, Boumaiza M, Hamouda SB, Ouni R, Bchiri S, Chaaban A, Gdoura M, Gorgi Y, Sfar I, Yalaoui S, Khelil JB, Hamzaoui A, Abdallah M, Cherif Y, Petres S, Mok CK, Escriou N, Quesney S, Dellagi K, Schoenhals M, Sarih M, Vigan-Womas I, Bettaieb J, Rourou S, Barbouche MR, Ahmed MB
Diagnostic Microbiology and Infectious Disease 2023
Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment
Takahashi M, Saito K, Ai T, Nojiri S, Khasawneh A, Paran FJ, Horiuchi Y, Takei S, Yamamoto T, Wakita M, Hiki M, Miida T, Naito T, Takahashi K, Tabe Y
PloS one 2023
Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study
Erbaş İC, Keleş YE, Erdeniz EH, Yılmaz AT, Yeşil E, Çakıcı Ö, Akça M, Ulu NK, Dinç F, Çiftdoğan DY, Öncel S, Kuyucu N, Tapısız A, Belet N
2023
Using SARS-CoV-2 Antibody Testing in COVID-19 Research
Amraotkar AR, Keith RJ, Palmer KE, Bhatnagar A
The American Journal of Medicine 2023
Label-Free SERS for Rapid Differentiation of SARS-CoV-2-Induced Serum Metabolic Profiles in Non-Hospitalized Adults
Chisanga M, Williams H, Boudreau D, Pelletier JN, Trottier S, Masson JF
Analytical Chemistry 2023
SARS-CoV-2-neutralising antibody BGB-DXP593 in mild-to-moderate COVID-19: a multicentre, randomised, double-blind, phase 2 trial
Vega R, Antila M, Perez C, Mookadam M, Xie F, Zhang W, Rizwan A, Yao Z, Rasko JE
2023
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
Rajagopala SV, Strickland BA, Pakala SB, Kimura KS, Shilts MH, Rosas-Salazar C, Brown HM, Freeman MH, Wessinger BC, Gupta V, Phillips E, Mallal SA, Turner JH, Das SR
Journal of virology 2023
Mathematical Modeling and Analysis of the Dynamics of RNA Viruses in Presence of Immunity and Treatment: A Case Study of SARS-CoV-2.
Hattaf K, El Karimi MI, Mohsen AA, Hajhouji Z, El Younoussi M, Yousfi N
Human vaccines 2023
Assessment of Reactivity to the Administration of the mRNA Vaccine after Six Months of Observation.
Slomka S, Zieba P, Rosiak O, Piekarska A
Human vaccines 2023
The role of immune activation and antigen persistence in acute and long COVID.
Opsteen S, Files JK, Fram T, Erdmann N
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2023
Dynamics of SARS-CoV-2 Spike-IgG throughout Three COVID-19 Vaccination Regimens: A 21-Month Longitudinal Study of 82 Norwegian Healthcare Workers
Augustinussen MH, Tylden GD, Rinaldo CH
Viruses 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
Parker E, Thomas J, Roper KJ, Ijaz S, Edwards T, Marchesin F, Katsanovskaja K, Lett L, Jones C, Hardwick HE, Davis C, Vink E, McDonald SE, Moore SC, Dicks S, Jegatheesan K, Cook NJ, Hope J, Cherepanov P, McClure MO, Baillie JK, Openshaw PJM, Turtle L, Ho A, Semple MG, Paxton WA, Tedder RS, Pollakis G
Frontiers in immunology 2023
Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19.
Jin X, Wang Y, Xu J, Li Y, Cheng F, Luo Y, Zhou H, Lin S, Xiao F, Zhang L, Lin Y, Zhang Z, Jin Y, Zheng F, Chen W, Zhu A, Tao Y, Zhao J, Kuo T, Li Y, Li L, Wen L, Ou R, Li F, Lin L, Zhang Y, Sun J, Yuan H, Zhuang Z, Sun H, Chen Z, Li J, Zhuo J, Chen D, Zhang S, Sun Y, Wei P, Yuan J, Xu T, Yang H, Wang J, Xu X, Zhong N, Xu Y, Sun K, Zhao J
Molecular genetics and genomics : MGG 2023
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Spicuzza L, Campagna D, Di Maria C, Sciacca E, Mancuso S, Vancheri C, Sambataro G
AIMS Microbiology 2023
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.
Chernyshev M, Sakharkar M, Connor RI, Dugan HL, Sheward DJ, Rappazzo CG, Stålmarck A, Forsell MNE, Wright PF, Corcoran M, Murrell B, Walker LM, Karlsson Hedestam GB
Nature Communications 2023
The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 severity: lessons learned from IgG avidity.
Hajilooi M, Keramat F, Moazenian A, Rastegari-Pouyani M, Solgi G
Medical Microbiology and Immunology 2023
Diagnostic performances of four commercially available assays for the identification of SARS-CoV-2, influenza type A/B virus and RSV.
Houwen C, van Lisdonk N, Bolier J, van Eekeren M, van Gaalen M, van Herk A, Paula Z, Peters N, de Reijer M, Mertens K, Thai KT
Diagnostic Microbiology and Infectious Disease 2023
Duration of SARS-CoV-2 RNA Shedding Is Significantly Influenced by Disease Severity, Bilateral Pulmonary Infiltrates, Antibiotic Treatment, and Diabetic Status: Consideration for Isolation Period.
Arfijanto MV, Asmarawati TP, Bramantono B, Rusli M, Rachman BE, Mahdi BA, Nasronudin N, Hadi U
2023
Multidisciplinary Center Care for Long COVID Syndrome - a Retrospective Cohort Study.
Bailey J, Lavelle B, Miller J, Jimenez M, Lim PH, Orban ZS, Clark JR, Tomar R, Ludwig A, Ali ST, Lank GK, Zielinski A, Mylvaganam R, Kalhan R, Muayed ME, Mutharasan RK, Liotta EM, Sznajder JI, Davidson C, Koralnik IJ, Sala MA
The American Journal of Medicine 2023
Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients
Sun R, Cai Y, Zhou Y, Bai G, Zhu A, Kong P, Sun J, Li Y, Liu Y, Liao W, Liu J, Cui N, Xiang J, Li B, Zhao J, Wu D, Ran P
Frontiers in immunology 2023
Are Measles-Mumps-Rubella (MMR) Antibodies Friends or Foes for Covid-19 Disease?
Salamony A, Shamikh Y, Amer K, Elnagdy T, Elnakib M, Yehia AA, Hassan W, Abdelsalam M
Archivum Immunologiae et Therapiae Experimentalis 2023
Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
Amellal H, Assaid N, Charoute H, Akarid K, Maaroufi A, Ezzikouri S, Sarih M
PloS one 2023
Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics
Franco-Luiz AP, Fernandes NM, Silva TB, Bernardes WP, Westin MR, Santos TG, Fernandes GD, Simões TC, Silva EF, Gava SG, Alves BM, de Carvalho Melo M, da Silva-Pereira RA, Alves PA, Fonseca CT
Frontiers in immunology 2023
The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh
Ahmed T, Akter A, Tauheed I, Akhtar M, Rahman SI, Khaton F, Ahmmed F, Firoj MG, Ferdous J, Afrad MH, Kawser Z, Hossain M, Hasnat MA, Sumon MA, Rashed A, Ghosh S, Banu S, Shirin T, Bhuiyan TR, Chowdhury F, Qadri F
Medicina 2023
Evaluation of humoral immune response in relation to COVID-19 severity over 1 year post-infection: critical cases higher humoral immune response than mild cases
Bang MS, Kim CM, Cho NH, Seo JW, Kim DY, Yun NR, Kim DM
Frontiers in immunology 2023
Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe
Soriano-Arandes A, Brett A, Buonsenso D, Emilsson L, de la Fuente Garcia I, Gkentzi D, Helve O, Kepp KP, Mossberg M, Muka T, Munro A, Papan C, Perramon-Malavez A, Schaltz-Buchholzer F, Smeesters PR, Zimmermann P
Frontiers in public health 2023
Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial
Deckert A, Anders S, Morales I, De Allegri M, Nguyen HT, Souares A, McMahon S, Meurer M, Burk R, Lou D, Brugnara L, Sand M, Koeppel L, Maier-Hein L, Ross T, Adler TJ, Brenner S, Dyer C, Herbst K, Ovchinnikova S, Marx M, Schnitzler P, Knop M, Bärnighausen T, Denkinger CM
2023
Profiling of SARS‐CoV‐2 neutralizing antibody‐associated antigenic peptides signature using proteome microarray
Wu M, Liu J, Wang X, Zhang X, Liang T, Chen L, Huang T, Li Y, Zheng C, Yang Y, Wang J, Yu X, Guo L, Yang J, Ren L
MedComm 2023
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.
Takahashi T, Ai T, Saito K, Nojiri S, Takahashi M, Igawa G, Yamamoto T, Khasawneh A, Paran FJ, Takei S, Horiuchi Y, Kanno T, Tobiume M, Hiki M, Wakita M, Miida T, Okuzawa A, Suzuki T, Takahashi K, Naito T, Tabe Y
PloS one 2023
Enhanced real-time mass spectrometry breath analysis for the diagnosis of COVID-19.
Roquencourt C, Salvator H, Bardin E, Lamy E, Farfour E, Naline E, Devillier P, Grassin-Delyle S
ERJ Open Research 2023
SARS-CoV-2 spike protein induces endothelial dysfunction in 3D engineered vascular networks
Stern B, Monteleone P, Zoldan J
Journal of biomedical materials research. Part A 2023
Utilizing Protein-Peptide Hybrid Microarray for Time-Resolved Diagnosis and Prognosis of COVID-19.
Zheng P, Liao B, Yang J, Cheng H, Cheng ZJ, Huang H, Luo W, Sun Y, Zhu Q, Deng Y, Yang L, Zhou Y, Wu W, Wu S, Cai W, Li Y, Mo X, Tan X, Li L, Ma H, Sun B
Microorganisms 2023
Associations of SARS-CoV-2 antibodies with birth outcomes: Results from three urban birth cohorts in the NIH environmental influences on child health outcomes program
Trasande L, Comstock SS, Herbstman JB, Margolis A, Alcedo G, Afanasyeva Y, Yu K, Lee W, Lawrence DA
PloS one 2023
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV.
Augello M, Bono V, Rovito R, Tincati C, Bianchi S, Taramasso L, Di Biagio A, Callegaro A, Maggiolo F, Borghi E, Monforte AD, Marchetti G
iScience 2023
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Bešević J, Lacey B, Callen H, Omiyale W, Conroy M, Feng Q, Crook DW, Doherty N, Ebner D, Eyre DW, Fry D, Horn E, Jones EY, Marsden BD, Peto TEA, Starkey F, Stuart D, Welsh S, Wood N, Young A, Young A, Effingham M, Collins R, Holliday J, Allen N
Journal of epidemiology and community health 2023
Vaccine Breakthrough Infection Leads to Distinct Profiles of Neutralizing Antibody Responses by SARS-CoV-2 Variant
Michael Seaman, Mark J Siedner, Julie Boucau, Christy Lavine, Fadi Ghantous, May Y. Liew, Josh I. Mathews, Arshdeep Singh, Caitlin Marino, James Regan, Rockib Uddin, Manish C Choudhary, James P. Flynn, Geoffrey Chen, Ashley Stuckwisch, Taryn Lipiner, Autumn Kittilson, Meghan Melberg, Rebecca F. Gilbert, Zahra Reynolds, Surabhi Iyer, Grace C Chamberlin, Tammy D Vyas, Jatin M. Vyas, Marcia B. Goldberg, Jeremy Luban, Jonathan Z Li, Amy K Barczak, Jacob E Lemieux
JCI Insight 2022
Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis
Y Okita, T Morita, A Kumanogoh
Inflammation and Regeneration 2022
NETosis and SARS-COV-2 infection related thrombosis: a narrative review
M Behzadifard, M Soleimani
Thrombosis Journal 2022
Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
N Amri, R Bégin, N Tessier, L Vachon, L Villeneuve, P Bégin, R Bazin, L Loubaki, C Martel
Pharmaceuticals (Basel, Switzerland) 2022
Immune responses to human respiratory coronaviruses infection in mouse models
Z Zhuang, D Liu, J Sun, F Li, J Zhao
Current Opinion in Virology 2022
Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood
J Qu, K Leirs, W Maes, M Imbrechts, N Callewaert, K Lagrou, N Geukens, J Lammertyn, D Spasic
ACS Sensors 2022
Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
A Cristiano, M Pieri, S Sarubbi, M Pelagalli, G Calugi, F Tomassetti, S Bernardini, M Nuccetelli
Clinical Immunology 2022
Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition
A Maciola, M Raja, M Pacenti, C Salata, G Silvestro, A Rosato, G Pasqual
Frontiers in immunology 2022
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients
E Garanina, S Hamza, R Stott-Marshall, E Martynova, M Markelova, Y Davidyuk, V Shakirova, N Kaushal, M Baranwal, I Khaertynova, A Rizvanov, T Foster, S Khaiboullina
Frontiers in microbiology 2022
Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study
K Hagman, M Hedenstierna, J Rudling, P Gille-Johnson, B Hammas, M Grabbe, J Jakobsson, J Dillner, J Ursing
Diagnostic Microbiology and Infectious Disease 2022
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Liu Z, Zhou J, Xu W, Deng W, Wang Y, Wang M, Wang Q, Hsieh M, Dong J, Wang X, Huang W, Xing L, He M, Tao C, Xie Y, Zhang Y, Wang Y, Zhao J, Yuan Z, Qin C, Jiang S, Lu L
Cell Research 2022
Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection
Turkkan A, Saglik I, Turan C, Sahin A, Akalin H, Ener B, Kara A, Celebi S, Sahin E, Hacimustafaoglu M
Irish Journal of Medical Science 2022
Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea
Park S, Chang SH, Lee JH, Lee JH, Ham JY, Kim YK, Kim SG, Ryoo NH
PloS one 2022
Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients
Kurano M, Ohmiya H, Kishi Y, Okada J, Nakano Y, Yokoyama R, Qian C, Xia F, He F, Zheng L, Yu Y, Jubishi D, Okamoto K, Moriya K, Kodama T, Yatomi Y
Frontiers in immunology 2022
Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection
Choteau M, Scohy A, Messe S, Luyckx M, Dechamps M, Montiel V, Yombi JC, Gruson D, Limaye N, Michiels T, Dumoutier L
Scientific Reports 2022
BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19
Kaznadzey A, Tutukina M, Bessonova T, Kireeva M, Mazo I
Frontiers in immunology 2022
Antibody Profiling in COVID-19 Patients with Different Severities by Using Spike Variant Protein Microarrays
Su WY, Du PX, Santos HM, Ho TS, Keskin BB, Pau CH, Yang AM, Chou YY, Shih HC, Syu GD
Analytical Chemistry 2022
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes
Garrido JL, Medina MA, Bravo F, McGee S, Fuentes-Villalobos F, Calvo M, Pinos Y, Bowman JW, Bahl CD, Barria MI, Brachman RA, Alvarez RA
Cell Reports 2022
The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA
Paul G, Strnad P, Wienand O, Krause U, Plecko T, Effenberger-Klein A, Giel KE, Junne F, Galante-Gottschalk A, Ehehalt S, Jürgensen JS
Infection 2022
Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19
Takita M, Yoshida T, Tsuchida T, Nakagama Y, Kido Y, Suzuki S, Imamura M, Kawahata K, Shimizu G, Yoshida H, Morikawa D, Kawaguchi T, Fujii S, Tsukuda J, Motohashi T, Fujitani S
Scientific Reports 2022
Clinical Characteristics of Immune Response in Asymptomatic Carriers and Symptomatic Patients With COVID-19
Li E, Wang S, He W, He J, Liu L, Zhang X, Yang S, Yan F, Gao Y, Liu B, Xia X
Frontiers in microbiology 2022
Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction
Hanssen DA, Penders J, Heijgele K, de Leede S, Mulder M, Bank LE, Slaats MH, Savelkoul PH, van Loo IH
2022
Kinetic Characteristics of Neutralizing Antibody Responses Vary among Patients with COVID-19
LI LH, TU HW, LIANG D, WEN CY, LI AA, LIN WY, HU KQ, HONG WS, LI YP, SU J, ZHAO ST, LI W, YUAN RY, ZHOU PP, HU FY, TANG XP, KE CW, KE BX, CAI WP
Biomedical and Environmental Sciences 2022
Self-administered, remote assessment of SARS-CoV-2 seroprevalence in health care workers
Card L, Litwin CM, Curry S, Mack EH, Nietert PJ, Meissner EG
The American Journal of the Medical Sciences 2022
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito R, Augello M, Ben-Haim A, Bono V, d\u2019Arminio Monforte A, Marchetti G
Frontiers in immunology 2022
Evaluation of Rapid Antigen Tests Using Nasal Samples to Diagnose SARS-CoV-2 in Symptomatic Patients
Alqahtani M, Abdulrahman A, Mustafa F, Alawadhi AI, Alalawi B, Mallah SI
Frontiers in public health 2022
SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
Srichatrapimuk S, Chookajorn T, Kochakarn T, Kirdlarp S, Pasomsub E, Chantratita W, Iamsirithaworn S, Kunakorn M, Thitithanyanont A, Sungkanuparph S, Phuphuakrat A
Travel Medicine and Infectious Disease 2022
Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital
Burke H, Freeman A, O\u2019Regan P, Wysocki O, Freitas A, Dushianthan A, Celinski M, Batchelor J, Phan H, Borca F, Sheard N, Williams S, Watson A, Fitzpatrick P, Landers D, Wilkinson T
BMJ Open 2022
The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases
Puchinger K, Castelletti N, Rubio-Acero R, Geldmacher C, Eser TM, Deák F, Paunovic I, Bakuli A, Saathoff E, von Meyer A, Markgraf A, Falk P, Reich J, Riess F, Girl P, Müller K, Radon K, Guggenbuehl Noller JM, Wölfel R, Hoelscher M, Kroidl I, Wieser A, Olbrich L
Virology 2022
SARS-CoV-2 IgM testing for travellers: a private pathology perspective from New South Wales and the Australian Capital Territory, Australia
Wehrhahn MC, Millan G, Newcombe JP, Long M, Keighley C, Whiting P, Chambers I
Pathology 2022
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
Rosas IO, Bräu N, Waters M, Go RC, Malhotra A, Hunter BD, Bhagani S, Skiest D, Savic S, Douglas IS, Garcia-Diaz J, Aziz MS, Cooper N, Youngstein T, Sorbo LD, Zerda DJ, Ustianowski A, Gracian AC, Blyth KG, Carratalà J, François B, Benfield T, Haslem D, Bonfanti P, van der Leest CH, Rohatgi N, Wiese L, Luyt CE, Bauer RN, Cai F, Lee IT, Matharu B, Metcalf L, Wildum S, Graham E, Tsai L, Bao M
2022
Structural mapping of antibody landscapes to human betacoronavirus spike proteins
Bangaru S, Antanasijevic A, Kose N, Sewall LM, Jackson AM, Suryadevara N, Zhan X, Torres JL, Copps J, de la Peña AT, Crowe JE Jr, Ward AB
Science Advances 2022
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection
Guihot A, Plu I, Soulié C, Rousseau A, Nakid-Cordero C, Dorgham K, Parizot C, Litvinova E, Mayaux J, Malet I, Quentric P, Combadière B, Combadière C, Bonduelle O, Adam L, Rosenbaum P, Beurton A, Hémon P, Debré P, Vieillard V, Autran B, Seilhean D, Charlotte F, Marcelin AG, Gorochov G, Luyt CE
Frontiers in immunology 2022
Characterization of the antibody response to SARS‐CoV‐2 in a mildly affected pediatric population
Kopanja S, Gattinger P, Schmidthaler K, Sieber J, Niepodziana K, Schlederer T, Weseslindtner L, Stiasny K, Götzinger F, Pickl WF, Frischer T, Valenta R, Szépfalusi Z
Pediatric Allergy and Immunology 2022
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
Zhang W, Chua BY, Selva KJ, Kedzierski L, Ashhurst TM, Haycroft ER, Shoffner-Beck SK, Hensen L, Boyd DF, James F, Mouhtouris E, Kwong JC, Chua KY, Drewett G, Copaescu A, Dobson JE, Rowntree LC, Habel JR, Allen LF, Koay HF, Neil JA, Gartner MJ, Lee CY, Andersson P, Khan SF, Blakeway L, Wisniewski J, McMahon JH, Vine EE, Cunningham AL, Audsley J, Thevarajan I, Seemann T, Sherry NL, Amanat F, Krammer F, Londrigan SL, Wakim LM, King NJ, Godfrey DI, Mackay LK, Thomas PG, Nicholson S, Arnold KB, Chung AW, Holmes NE, Smibert OC, Trubiano JA, Gordon CL, Nguyen TH, Kedzierska K
Nature Communications 2022
Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients
Lagedal R, Eriksson O, Sörman A, Huckriede JB, Kristensen B, Franzén S, Larsson A, Bergqvist A, Alving K, Forslund A, Persson B, Ekdahl KN, Garcia de Frutos P, Nilsson B, Nicolaes GA, Lipcsey M, Hultström M, Frithiof R
Journal of Clinical Medicine 2022
SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests.
Kay GA, Owen SI, Giorgi E, Clark DJ, Williams CT, Menzies S, Cuevas LE, Davies BMO, Eckersley NM, Hughes GL, Kirwan DE, Krishna S, Patterson EI, Planche T, Staines HM, Adams ER
Scientific Reports 2022
Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19.
Chen L, Pang P, Qi H, Yan K, Ren Y, Ma M, Cao R, Li H, Hu C, Li Y, Xia J, Lai D, Dong Y, Jiang H, Zhang H, Shan H, Tao S, Liu S
Frontiers in immunology 2022
Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
Mahallawi WH, Alsarani MA, Aljohani RH, Alluhaibi AA, Alamri TH, Ibrahim NA, Mahallawi KH, Khabourd OF
Annals of Saudi medicine 2022
Multiscale Model of Antiviral Timing, Potency, and Heterogeneity Effects on an Epithelial Tissue Patch Infected by SARS-CoV-2
Ferrari Gianlupi J, Mapder T, Sego TJ, Sluka JP, Quinney SK, Craig M, Stratford RE Jr, Glazier JA
Viruses 2022
Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection.
Yang Y, Yang M, Peng Y, Liang Y, Wei J, Xing L, Guo L, Li X, Li J, Wang J, Li M, Xu Z, Zhang M, Wang F, Shi Y, Yuan J, Liu Y
Nature Microbiology 2022
Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates
Castro Dopico X, Muschiol S, Grinberg NF, Aleman S, Sheward DJ, Hanke L, Ahl M, Vikström L, Forsell M, Coquet JM, McInerney G, Dillner J, Bogdanovic G, Murrell B, Albert J, Wallace C, Karlsson Hedestam GB
IBMS BoneKEy 2022
A method comparison of three immunoassays for detection of neutralizing antibodies against SARS‐CoV‐2 receptor‐binding domain in individuals with adenovirus type‐5‐vectored COVID‐19 vaccination
Chen H, Yu W, Gao X, Jiang W, Li X, Liu G, Yang Y
Journal of Clinical Laboratory Analysis 2022
Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study
Dinç HÖ, Demirci M, Özdemir YE, Sirekbasan S, Aktaş AN, Karaali R, Tok YT, Özbey D, Akçin R, Gareayaghi N, Kuşkucu MA, Midilli K, Aygün G, Sarıbaş S, Kocazeybek B
Balkan Medical Journal 2022
Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression
Mohanraj D, Whitelegg A
International Archives of Allergy and Immunology 2022
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors
Brümmer LE, Katzenschlager S, McGrath S, Schmitz S, Gaeddert M, Erdmann C, Bota M, Grilli M, Larmann J, Weigand MA, Pollock NR, Macé A, Erkosar B, Carmona S, Sacks JA, Ongarello S, Denkinger CM
PLoS Medicine 2022
Predictors of COVID-19 severity and hospitalization: A survey-based study from Jordan
Kofahi HM, Swedan SF, Khabour OF, Nimer RM
Informatics in medicine unlocked 2022
Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients.
Malik IA, Ramadori G
Biology 2022
Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?
Pavlidis G, Kampolis CF, Perlepe G, Pagonis A, Maniotis C, Koullias E, Kranidioti H, Kyritsis A, Pavlou E, Sinis S, Pirounaki M, Vassilopoulos D, Gourgoulianis K, Pantazopoulos I
In vivo (Athens, Greece) 2022
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
Yan LN, Liu PP, Li XG, Zhou SJ, Li H, Wang ZY, Shen F, Lu BC, Long Y, Xiao X, Wang ZD, Li D, Han HJ, Yu H, Zhou SH, Lv WL, Yu XJ
Frontiers in microbiology 2022
Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”
Ali ST, Kang AK, Patel TR, Clark JR, Perez\u2010Giraldo GS, Orban ZS, Lim PH, Jimenez M, Graham EL, Batra A, Liotta EM, Koralnik IJ
Annals of Clinical and Translational Neurology 2022
Correlates of protection against SARS-CoV-2 infection and COVID-19 disease.
Goldblatt D, Alter G, Crotty S, Plotkin SA
Immunological Reviews 2022
Human IgG antibody responses to severe acute respiratory syndrome coronavirus 2 viral antigens receptor-binding domain, spike, and nucleocapsid, in vaccinated adults from Merida, Mexico.
Puerta-Guardo H, Parra-Cardeña M, Peña-Miranda F, Flores-Quintal F, Granja-Pérez P, Villanueva-Jorge S, González-Losa R, Conde-Ferraez L, Gómez-Carballo J, Vazquez-Prokopec G, Earnest JT, Manrique-Saide P, Ayora-Talavera G
Frontiers in Medicine 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G
PloS one 2022
Serologic Tests for COVID-19 Infections and Vaccination
Plotkin S
The Pediatric Infectious Disease Journal 2022
SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome
Kanduc D
2022
Antibody levels to SARS‐CoV‐2 spike protein in mothers and children from delivery to six months later
Martin\u2010Vicente M, Carrasco I, Muñoz\u2010Gomez MJ, Lobo AH, Mas V, Vigil\u2010Vázquez S, Vázquez M, Manzanares A, Cano O, Alonso R, Sepúlveda\u2010Crespo D, Tarancón\u2010Díez L, Muñoz\u2010Fernández MÁ, Muñoz\u2010Chapuli M, Resino S, Navarro ML, Martinez I
2022
Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.
Lubetzky M, Zhao Z, Sukhu A, Sharma V, Sultan S, Kapur Z, Albakry S, Craig-Schapiro R, Lee JR, Salinas T, Aull M, Kapur S, Cushing M, Dadhania DM
Nephrology Dialysis Transplantation 2022
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis B, Ramos SG, Piccin M, Nonato OC, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon E, Salazar A, Caballero O, Santiago H, Machado A, Silva JS, da Fonseca F, Fernandes AP, Teixeira SR, Gazzinelli RT
Nature Communications 2022
Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Dan J, da Silva Antunes R, Grifoni A, Weiskopf D, Crotty S, Sette A
Clinical Infectious Diseases 2022
A simple model of COVID-19 explains disease severity and the effect of treatments
Sanche S, Cassidy T, Chu P, Perelson AS, Ribeiro RM, Ke R
Scientific Reports 2022
Dysregulation of immunity in COVID-19 and SLE.
Hejazian SS, Hejazian SM, Farnood F, Abedi Azar S
InflammoPharmacology 2022
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients.
André S, Azarias da Silva M, Picard M, Alleaume-Buteau A, Kundura L, Cezar R, Soudaramourty C, André SC, Mendes-Frias A, Carvalho A, Capela C, Pedrosa J, Gil Castro A, Loubet P, Sotto A, Muller L, Lefrant JY, Roger C, Claret PG, Duvnjak S, Tran TA, Zghidi-Abouzid O, Nioche P, Silvestre R, Corbeau P, Mammano F, Estaquier J
Cell Death and Disease 2022
High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia
Alzabeedi KH, Makhlof RT, Bakri RA, Ewis AA, Alhamdi HW, Habeebullah TM, Khogeer AA, Mulla EA, Roshan SA, Qabbani FH, Hafez FH, Alqurashi RG, Babalghaith MO, Ghouth AA, Alhazmi MH, Fallatah OM, Badahdah SA, Endergiri DI, Albarakati BM, Abdelwahab SF
Human vaccines 2022
Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
Larkey NE, Ewaisha R, Lasho MA, Roforth MM, Granger D, Jerde CR, Wu L, Gorsh A, Klassen SA, Senefeld JW, Joyner MJ, Baumann NA, Theel ES, Mills JR
Microbiology spectrum 2022
Mucosal gene expression in response to SARS-CoV-2 is associated with early viral load
Rajagopala SV, Strickland BA, Pakala SB, Kimura KS, Shilts MH, Rosas-Salazar C, Brown HM, Freeman MH, Wessinger BC, Gupta V, Phillips E, Mallal SA, Turner JH, Das SR
2022
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, Yamamoto T, Yuri M, Takei S, Saito K, Horiuchi Y, Kanno T, Tobiume M, Khasawneh A, Paran FJ, Hiki M, Wakita M, Miida T, Suzuki T, Okuzawa A, Takahashi K, Naito T, Tabe Y
Scientific Reports 2022
The striking mimics between COVID-19 and malaria: A review
Konozy EH, Osman ME, Ghartey-Kwansah G, Abushama HM
Frontiers in immunology 2022
COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
Huhn G, Poorbaugh J, Zhang L, Beasley S, Nirula A, Brothers J, Welbel S, Wilson J, Gillani S, Weber KM, Morack R, Keckler K, Benschop RJ
PloS one 2022
Early COVID-19 respiratory risk stratification using machine learning.
Douglas MJ, Bell BW, Kinney A, Pungitore SA, Toner BP
2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization
Bertoletti A, Le Bert N, Tan AT
International journal of molecular sciences 2022
Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform
Ali MA, Zhang GF, Hu C, Yuan B, Jahan S, Kitsios GD, Morris A, Gao S, Panat R
Journal of Medical Virology 2022
Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study
Gunawardana M, Webster S, Rivera S, Cortez JM Jr, Breslin J, Pinales C, Buser C, Ibarrondo FJ, Yang OO, Bobardt M, Gallay PA, Adler AP, Ramirez CM, Anton PA, Baum MM
2022
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.
Papanikolaou C, Rapti V, Stellas D, Stefanou DT, Syrigos K, Pavlakis GN, Souliotis VL
Human vaccines 2022
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
Rapti V, Tsaganos T, Vathiotis IA, Syrigos NK, Li P, Poulakou G
Human vaccines 2022
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
Rovito R, Bono V, Augello M, Tincati C, Mainoldi F, Beaudoin-Bussières G, Tauzin A, Bianchi S, Hadla M, Yellenki V, d\u2019Arminio Monforte A, Casola S, Borghi E, Finzi A, Marchetti G
Scientific Reports 2022
Buffy Coat Transcriptomic Analysis Reveals Alterations in Host Cell Protein Synthesis and Cell Cycle in Severe COVID-19 Patients.
Cavalcante LTF, da Fonseca GC, Amado Leon LA, Salvio AL, Brustolini OJ, Gerber AL, Guimarães APC, Marques CAB, Fernandes RA, Ramos Filho CHF, Kader RL, Pimentel Amaro M, da Costa Gonçalves JP, Vieira Alves-Leon S, Vasconcelos ATR
International journal of molecular sciences 2022
Determining the SARS-CoV-2 Anti-Spike Cutoff Level Denoting Neutralizing Activity Using Two Commercial Kits.
El-Ghitany EM, Hashish MH, Farghaly AG, Omran EA
Human vaccines 2022
Antibody Dependent Enhancement of SARS-CoV-2 Infection in the Era of Rapid Vaccine Development
Al Dossary R
Medical Archives 2022
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Zhang A, Stacey HD, D\u2019Agostino MR, Tugg Y, Marzok A, Miller MS
Nature reviews. Immunology 2022
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes.
Serna-Muñoz R, Hernández-Terán A, Soto-Nava M, Tapia-Trejo D, Ávila-Ríos S, Mejía-Nepomuceno F, García E, Castillejos-López M, Higuera-Iglesias AL, Aquino-Gálvez A, Thirion-Romero I, Pérez-Padilla R, Aguilar-Faisal JL, Vázquez-Pérez JA
Human vaccines 2022
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses.
Noto A, Joo V, Mancarella A, Suffiotti M, Pellaton C, Fenwick C, Perreau M, Pantaleo G
Viruses 2022
Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation.
Chao TL, Lee WH, Hu HC, Lin YC, Ho SY, Chen HH, Chen CP, Tsaih YM, Fang RD, Leong SM, Cheng YC, Peng M, Cheng SH, Cheng CY, Chang SY
2022
Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients
He S, Fang Y, Yang J, Wang W
Frontiers in public health 2022
Community-Based Seroprevelance of SARS-CoV-2 in Saudi Arabia.
Alassaf L, Almudarra S, Almudaiheem A, Almutlaq H, Alqunaibet A, Alseraihi H, Alaswad R, Khoja AT, AlAbdulkareem K, AlSaif F, Abu Saris R
Cureus 2022
Changing Features of Liver Injury in COVID-19 Patients: Impact of Infection with the SARS-CoV-2 Delta (B.1.617.2) Variants
Choi CW, Sung HK, Jeong JY, Lim DH, Choi J, Kwon HC, Nam S, Kim Y, Chin B
Infection & Chemotherapy 2022
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Mullender C, da Costa KA, Alrubayyi A, Pett SL, Peppa D
2022
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time
Gentles LE, Kehoe L, Crawford KH, Lacombe K, Dickerson J, Wolf C, Yuan J, Schuler S, Watson JT, Nyanseor S, Briggs-Hagen M, Saydah S, Midgley CM, Pringle K, Chu H, Bloom JD, Englund JA
2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews J, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE
2022
Does common cold coronavirus infection protect against severe SARS-CoV2 disease?
David K. Meyerholz, Stanley Perlman
Journal of Clinical Investigation 2021
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander, Stephanie Henson, Daniel Monaco, Athena Chen, Kirsten Littlefield, Evan Bloch, Eric Fujimura, Ingo Ruczinski, Andrew Crowley, Harini Natarajan, Savannah Butler, Joshua Weiner, Mamie Li, Tania Bonny, Sarah Benner, Ashwin Balagopal, David Sullivan, Shmuel Shoham, Thomas Quinn, Susan Eshleman, Arturo Casadevall, Andrew Redd, Oliver Laeyendecker, Margaret Ackerman, Andrew Pekosz, Steve Elledge, Matthew Robinson, Aaron Tobian, H. Larman
Journal of Clinical Investigation 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes
Yijia Li, Alexis M. Schneider, Arnav Mehta, Moshe Sade-Feldman, Kyle Kays, Matteo Gentili, Nicole Charland, Anna L. K. Gonye, Irena Gushterova, Hargun Khanna, Thomas J LaSalle, Kendall Lavin-Parsons, Brendan Lilley, Carl Lodenstein, Kasidet Manakongtreecheep, Justin Margolin, Brenna McKaig, Blair Alden Parry, Maricarmen Rojas-Lopez, Brian C Russo, Nihaarika Sharma, Jessica Tantivit, Molly Thomas, James Regan, James P Flynn, Alexandra-Chloé Villani, Nir Hacohen, Marcia B. Goldberg, Michael R Filbin, Jonathan Li
Journal of Clinical Investigation 2021
Multisystem Inflammatory Syndrome in Children is driven by zonulin-dependent loss of gut mucosal barrier
Lael M. Yonker, Tal Gilboa, Alana F. Ogata, Yasmeen Senussi, Roey Lazarovits, Brittany P Boribong, Yannic C Bartsch, Maggie Loiselle, Magali Noval Rivas, Rebecca A Porritt, Rosiane Lima, Jameson P Davis, Eva J. Farkas, Madeleine D Burns, Nicola Young, Vinay S Mahajan, Soroush Hajizadeh, Xcanda I. Herrera Lopez, Johannes Kreuzer, Robert Morris, Enid E Martinez, Isaac Han, Kettner Griswold Jr., Nicholas C Barry, David B Thompson, George Church, Andrea G. Edlow, Wilhelm Haas, Shiv Pillai, Moshe Arditi, Galit Alter, David R. Walt, Alessio Fasano
Journal of Clinical Investigation 2021
Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients
Muriel Aguilar-Bretones, Brenda M. Westerhuis, Matthijs P. Raadsen, Erwin de Bruin, Felicity D. Chandler, Nisreen M.A. Okba, Bart L. Haagmans, Thomas Langerak, Henrik Endeman, Johannes P.C. van den Akker, Diederik Gommers, Eric C.M. van Gorp, Corine H. GeurtsvanKessel, Rory D. de Vries, Ron A.M. Fouchier, Barry H.G. Rockx, Marion Koopmans, Gijsbert P. van Nierop
Journal of Clinical Investigation 2021
Treatment of Severe COVID-19 with Convalescent Plasma in Bronx, NYC
Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, Ariel S. Wirchnianski, Monika Paroder, Karen Fehn, Leana Serrano-Rahman, Rachelle Babb, Uzma N. Sarwar, Denise Haslwanter, Ethan Laudermilch, Catalina Florez, M. Eugenia Dieterle, Rohit K Jangra, J. Maximilian Fels, Karen Tong, Margarette C. Mariano, Olivia Vergnolle, George I. Georgiev, Natalia G. Herrera, Ryan J. Malonis, Jose A. Quiroz, Nicholas C. Morano, Gregory J. Krause, Joseph M. Sweeney, Kelsie Cowman, Stephanie A Allen, Jayabhargav Annam, Ariella Applebaum, Daniel Barboto, Ahmed Khokhar, Brianna J. Lally, Audrey Lee, Max Lee, Avinash Malaviya, Reise Sample, Xiuyi A Yang, Yang Li, Rafael E Ruiz, Raja Thota, Jason Barnhill, Doctor Y. Goldstein, Joan Uehlinger, Scott J. Garforth, Steven C. Almo, Jonathan R. Lai, Morayma Reyes Gil, Amy S. Fox, Kartik Chandran, Tao Wang, Johanna P Daily, Liise-anne Pirofski
JCI Insight 2021
Effective virus-neutralizing activities in antisera from the first wave of severe COVID-19 survivors
Yang Han, Peipei Liu, Yang Qiu, Jie Zhou, Ying Liu, Xujuan Hu, Qingyu Yang, Rui Huang, Xinyue Wen, Hao Song, Pengcheng Yu, Mengjie Yang, Jing Zhang, William J. Liu, Ke Peng, Guizhen Wu, Dingyu Zhang, Xi Zhou, Ying Wu
JCI Insight 2021
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
Michele Donato, Steven Park, Melissa Baker, Robert Korngold, Alison Morawski, Xue Geng, Ming Tan, Andrew Ip, Stuart Goldberg, Scott D. Rowley, Kar F Chow, Emily Brown, Joshua Zenreich, Phyllis McKiernan, Kathryn Buttner, Anna Ullrich, Laura Long, Rena Feinman, Andrea Ricourt, Marlo Kemp, Mariefel Vendivil, Hyung C. Suh, Bindu Balani, Cristina Cicogna, Rani Sebti, Abdulla Al-Khan, Steven J. Sperber, Samit Desai, Stacey L. Fanning, Danit Arad, Ronaldo C. Go, Elizabeth Tam, Keith Rose, Sean Sadikot, David S Siegel, Martin Gutierrez, Tatyana Feldman, Andre Goy, Andrew Pecora, Noa Biran, Lori A. Leslie, Alfred Gillio, Sarah Timmapuri, Michele S. Boonstra, Sam Singer, Sukhdeep Kaur, Ernest Richards, David S Perlin
JCI Insight 2021
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
Alexis R. Demonbreun, Thomas W McDade, Lorenzo L Pesce, Lauren A Vaught, Nina Reiser, Elena Bogdanovic, Matthew P Velez, Ryan Hsieh, Lacy M Simons, Rana Saber, Daniel Ryan, Michael G Ison, Judd F. Hultquist, John T. Wilkins, Richard T. D'Aquila, Brian Mustanski, Elizabeth M McNally
JCI Insight 2021
SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma
JD Deere, TD Carroll, J Dutra, L Fritts, RL Sammak, JA Yee, KJ Olstad, JR Reader, A Kistler, J Kamm, CD Germanio, YS Lakshmanappa, SR Elizaldi, JW Roh, G Simmons, J Watanabe, RE Pollard, J Usachenko, R Immareddy, BA Schmidt, SL OConnor, J DeRisi, MP Busch, SS Iyer, KK Rompay, DJ Hartigan-OConnor, CJ Miller, MA Martinez
Microbiology spectrum 2021
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, RA Booth, Y Durocher, M Cuperlovic-Culf, SA Bennett, AM Crawley, PM Giguère, C Cooper, MA Langlois
EBioMedicine 2021
Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial
K Cho, SC Keithly, KE Kurgansky, AL Madenci, H Gerlovin, H Marucci-Wellman, A Doubleday, ER Thomas, Y Park, YL Ho, JD Sugimoto, KP Moore, AC Peterson, C Hoag, K Gupta, K Jeans, M Klote, R Ramoni, GD Huang, JP Casas, DR Gagnon, MA Hernán, NL Smith, JM Gaziano
The Journal of Infectious Diseases 2021
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
AE John, C Joseph, G Jenkins, AL Tatler
Immunological Reviews 2021
COVID-19 convalescent plasma composition and immunological effects in severe patients
Y Acosta-Ampudia, DM Monsalve, M Rojas, Y Rodríguez, JE Gallo, JC Salazar-Uribe, MJ Santander, MP Cala, W Zapata, MI Zapata, R Manrique, JM Pardo-Oviedo, B Camacho, C Ramírez-Santana, JM Anaya
Journal of Autoimmunity 2021
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan, M Ackermann, J Helms, D Jonigk, R Chocron, GB Pier, N Gendron, S Pons, JL Diehl, C Margadant, C Guerin, EJ Huijbers, A Philippe, N Chapuis, P Nowak-Sliwinska, C Karagiannidis, O Sanchez, P Kümpers, D Skurnik, AM Randi, AW Griffioen
Angiogenesis 2021
Mapping and role of T cell response in SARS-CoV-2–infected mice
Z Zhuang, X Lai, J Sun, Z Chen, Z Zhang, J Dai, D Liu, Y Li, F Li, Y Wang, A Zhu, J Wang, W Yang, J Huang, X Li, L Hu, L Wen, J Zhuo, Y Zhang, D Chen, S Li, S Huang, Y Shi, K Zheng, N Zhong, J Zhao, D Zhou, J Zhao
Journal of Experimental Medicine 2021
Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection
U Sahu, D Biswas, AK Singh, P Khare
VirusDisease 2021
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
LY Wong, S Perlman
Nature Reviews Immunology 2021
Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
Q Lei, H Hou, C Yu, Y Zhang, JL Ndzouboukou, X Lin, Z Yao, H Fu, Z Sun, F Wang, X Fan, B Xu
Journal of Immunology Research 2021
The conundrum of current anti-SARS-CoV-2 vaccines
M Federico
Cytokine & Growth Factor Reviews 2021
Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19
DP Smith, O Oechsle, MJ Rawling, E Savory, AM Lacoste, PJ Richardson
Frontiers in pharmacology 2021
Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients
Y Guo, T Li, X Xia, B Su, H Li, Y Feng, J Han, X Wang, L Jia, Z Bao, J Li, Y Liu, L Li
Frontiers in immunology 2021
Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
L Pirofski
Clinical Infectious Diseases 2021
Adaptive immunity to SARS-CoV-2 and COVID-19
A Sette, S Crotty
Cell 2021
Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19
Z Meng, S Guo, Y Zhou, M Li, M Wang, B Ying
Signal Transduction and Targeted Therapy 2021
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SA Klassen, JW Senefeld, KA Senese, PW Johnson, CC Wiggins, SE Baker, N van Helmond, KA Bruno, L Pirofski, S Shoham, BJ Grossman, JP Henderson, RS Wright, DL Fairweather, NS Paneth, RE Carter, A Casadevall, MJ Joyner
Frontiers in Medicine 2021
Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects
J Zheng, Y Deng, Z Zhao, B Mao, M Lu, Y Lin, A Huang
Cellular and Molecular Immunology 2021
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
M Dogan, L Kozhaya, L Placek, C Gunter, M Yigit, R Hardy, M Plassmeyer, P Coatney, K Lillard, Z Bukhari, M Kleinberg, C Hayes, M Arditi, E Klapper, N Merin, BT Liang, R Gupta, O Alpan, D Unutmaz
2021
Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case–control study
MN Klein, EW Wang, P Zimand, H Beauchamp, C Donis, MD Ward, A Martinez-Hernandez, A Tabatabai, JW Baddley, EM Bloch, KE Mullins, MJ Fontaine
Journal of clinical pathology 2021
Recent biotechnological advances as potential intervention strategies against COVID-19
N Lobo-Galo, JC Gálvez-Ruíz, AP Balderrama-Carmona, NP Silva-Beltrán, E Ruiz-Bustos
3 Biotech 2021
SARS-CoV-2-specific T cells in infection and vaccination
A Bertoletti, NL Bert, M Qui, AT Tan
Cellular and Molecular Immunology 2021
Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19
DM Kim, Y Kim, JW Seo, J Lee, U Park, NY Ha, J Koh, H Park, JW Lee, HJ Ro, NR Yun, DY Kim, SH Yoon, YS Na, DS Moon, SC Lim, CM Kim, K Jeon, JG Kang, NY Jang, H Jeong, J Kim, S Cheon, KM Sohn, JY Moon, S Kym, SR Han, MS Lee, HJ Kim, WY Park, JY Choi, HW Shin, HY Kim, CH Cho, YK Jeon, YS Kim, NH Cho
Cell Reports 2021
Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider
A Najm, A Alunno, X Mariette, B Terrier, GD Marco, J Emmel, L Mason, DG McGonagle, PM Machado
RMD Open 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
A Alunno, A Najm, PM Machado, H Bertheussen, GR Burmester, F Carubbi, GD Marco, R Giacomelli, O Hermine, JD Isaacs, I Koné-Paut, C Magro-Checa, I McInnes, PL Meroni, L Quartuccio, AV Ramanan, M Ramos-Casals, JR Carrio, H Schulze-Koops, TA Stamm, SW Tas, B Terrier, DG McGonagle, X Mariette
Annals of the rheumatic diseases 2021
Single-cell immunology of SARS-CoV-2 infection
Y Tian, LN Carpp, HE Miller, M Zager, EW Newell, R Gottardo
Nature Biotechnology 2021
Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
W Aguilar-Jiménez, L Flórez-Álvarez, DS Rincón, D Marín-Palma, A Sánchez-Martínez, J Martínez, MI Zapata, JD Loaiza, C Cárdenas, F Guzmán, PA Velilla, NA Taborda, W Zapata, JC Hernández, FJ Díaz, MT Rugeles
Biomédica 2021
Dynamics of host immune responses to SARS-CoV-2
R Taherkhani, S Taherkhani, F Farshadpour
World journal of clinical cases 2021
Comprehensive analysis of COVID-19 during pregnancy
KM Moore, MS Suthar
Biochemical and Biophysical Research Communications 2021
Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity
Wuji Zhang, Brendon Chua, Kevin Selva, Lukasz Kedzierski, Thomas Ashhurst, Ebene Haycroft, Suzanne Shoffner, Luca Hensen, David Boyd, Fiona James, Effie Mouhtouris, Jason Kwong, Kyra Chua, George Drewett, Ana Copaescu, Julie Dobson, Louise Rowntree, Jennifer Habel, Lilith Allen, Hui-Fern Koay, Jessica Neil, Matthew Gartner, Christina Lee, Patiyan Andersson, Torsten Seemann, Norelle Sherry, Fatima Amanat, Florian Krammer, Sarah Londrigan, Linda Wakim, Nicholas King, Dale Godfrey, Laura Mackay, Paul Thomas, Suellen Nicholson, Kelly Arnold, Amy Chung, Natasha Holmes, Olivia Smibert, Jason Trubiano, Claire Gordon, Thi Nguyen, Katherine Kedzierska
Research square 2021
The intersection of COVID-19 and autoimmunity: What is our current understanding?
NE Winchester, C Calabrese, L Calabrese
Pathogens and Immunity 2021
Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
F Venet, M Cour, T Rimmelé, S Viel, H Yonis, R Coudereau, C Amaz, P Abraham, C Monard, JS Casalegno, K Brengel-Pesce, AC Lukaszewicz, L Argaud, G Monneret
Critical Care 2021
Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis
TJ Loftus, R Ungaro, M Dirain, PA Efron, MB Mazer, KE Remy, RS Hotchkiss, L Zhong, R Bacher, P Starostik, LL Moldawer, SC Brakenridge
Frontiers in immunology 2021
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
I Jarlhelt, SK Nielsen, CX Jahn, CB Hansen, L Pérez-Alós, A Rosbjerg, R Bayarri-Olmos, MO Skjoedt, P Garred
Frontiers in immunology 2021
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study
Y Shionoya, T Taniguchi, H Kasai, N Sakuma, S Imai, K Shikano, S Takayanagi, M Yahaba, T Nakada, H Igari, S Sakao, T Suzuki, AR Zivkovic
PloS one 2021
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
MG Noval, ME Kaczmarek, A Koide, BA Rodriguez-Rodriguez, P Louie, T Tada, T Hattori, T Panchenko, LA Romero, KW Teng, A Bazley, M de Vries, MI Samanovic, JN Weiser, I Aifantis, J Cangiarella, MJ Mulligan, L Desvignes, M Dittmann, NR Landau, M Aguero-Rosenfeld, S Koide, KA Stapleford
Scientific Reports 2021
Immune Responses against SARS-CoV-2—Questions and Experiences
H Mangge, M Kneihsl, W Schnedl, G Sendlhofer, F Curcio, R Domenis
Biomedicines 2021
Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection
P Zimmermann, N Curtis
The Pediatric Infectious Disease Journal 2021
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
K Nayak, K Gottimukkala, S Kumar, ES Reddy, VV Edara, R Kauffman, K Floyd, G Mantus, D Savargaonkar, PK Goel, S Arora, M Rahi, CW Davis, S Linderman, J Wrammert, MS Suthar, R Ahmed, A Sharma, K Murali-Krishna, A Chandele
Virology 2021
SARS-CoV-2 Antibody Testing: Where Are We Now?
E Smerczak
Laboratory Medicine 2021
Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2
MF Amjadi, SE OConnell, T Armbrust, AM Mergaert, SR Narpala, PJ Halfmann, SJ Bashar, CR Glover, AS Heffron, A Taylor, B Flach, DH OConnor, Y Kawaoka, AB McDermott, AK Sethi, MA Shelef
ImmunoHorizons 2021
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study
S Karuna, SS Li, S Grant, SR Walsh, I Frank, M Casapia, M Trahey, O Hyrien, L Fisher, MD Miner, AK Randhawa, L Polakowski, JG Kublin, L Corey, D Montefiori, JG Beeson
PLoS Medicine 2021
Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
R González-Stegmaier, K Cereceda, JL Briones, C Beltran-Pávez, A Oyarzún-Arrau, S Riquelme-Barrios, C Selman, F Yarad, M Mahave, C Caglevic, R Morales, A Aguirre, F Valiente-Echeverría, R Soto-Rifo, H Marsiglia, R Gazitua, F Villarroel-Espindola, B Xu
Journal of Immunology Research 2021
Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment
D Focosi, M Franchini
European Journal of Haematology 2021
Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report
MD Rienzo, ML Foddai, L Conti, C Mandoj, S Iaboni, I Saladini, C Castilletti, G Matusali, DR Donno, L Marchioni, S Ianniello, A Corpolongo, M Palange, G Ciliberto, G Piaggio, FD Marco
Frontiers in immunology 2021
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
CE Chan, SG Seah, DH Chye, S Massey, M Torres, AP Lim, SK Wong, JJ Neo, PS Wong, JH Lim, GS Loh, D Wang, JD Boyd-Kirkup, S Guan, D Thakkar, GH Teo, K Purushotorman, PE Hutchinson, BE Young, JG Low, PA MacAry, H Hentze, VS Prativadibhayankara, K Ethirajulu, JE Comer, CT Tseng, AD Barrett, PJ Ingram, T Brasel, BJ Hanson, K Harrod
PloS one 2021
The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients
H Luo, T Jia, J Chen, S Zeng, Z Qiu, S Wu, X Li, Y Lei, X Wang, W Wu, R Zhang, X Zou, T Feng, R Ding, Y Zhang, YQ Chen, C Sun, T Wang, S Fang, Y Shu
Frontiers in immunology 2021
Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area
S Jain, K Garg, SM Tran, IL Rask, M Tarczon, V Nandi, DA Kessler, D Strauss, BS Sachais, K Yazdanbakhsh, S Rehmani, L Luchsinger, PA Shi
Transfusion 2021
Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset
J Guo, L Li, Q Wu, H Li, Y Li, X Hou, F Yang, Z Qin
Future Virology 2021
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
J Schmidt, S Berghaus, F Blessing, F Wenzel, H Herbeck, J Blessing, P Schierack, S Rödiger, D Roggenbuck
GeroScience 2021
Seroconversion among COVID-19 patients admitted in a dedicated COVID hospital: A longitudinal prospective study of 1000 patients
AK Yadav, S Ghosh, A Kotwal, SK Kaushik, S Bobdey, R Sahu, S Kapoor, DS Faujdar, PT Teli, V Anand
Medical Journal Armed Forces India 2021
Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis
HR Savage, VS Santos, T Edwards, E Giorgi, S Krishna, TD Planche, HM Staines, JR Fitchett, DE Kirwan, AI Atienzar, DJ Clark, ER Adams, LE Cuevas, T Lin
PLoS neglected tropical diseases 2021
Antibody Responses in COVID-19: A Review
M Chvatal-Medina, Y Mendez-Cortina, PJ Patiño, PA Velilla, MT Rugeles
Frontiers in immunology 2021
Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
V Sasisekharan, N Pentakota, A Jayaraman, K Tharakaraman, GN Wogan, U Narayanasami
Proceedings of the National Academy of Sciences 2021
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
V Legros, S Denolly, M Vogrig, B Boson, E Siret, J Rigaill, S Pillet, F Grattard, S Gonzalo, P Verhoeven, O Allatif, P Berthelot, C Pélissier, G Thiery, E Botelho-Nevers, G Millet, J Morel, S Paul, T Walzer, FL Cosset, T Bourlet, B Pozzetto
Cellular and Molecular Immunology 2021
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
NY Pang, AS Pang, VT Chow, DY Wang
Military Medical Research 2021
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
D Alfego, A Sullivan, B Poirier, J Williams, A Grover, L Gillim, D Adcock, S Letovsky
2021
Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors
Z Szabó, T Szabó, K Bodó, G Kemenesi, F Földes, K Kristóf, E Barabás, B Vásárhelyi, Z Prohászka, E Fodor, F Jakab, T Berki, Z Lacza
Practical Laboratory Medicine 2021
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
X Feng, J Yin, J Zhang, Y Hu, Y Ouyang, S Qiao, H Zhao, T Zhang, X Li, L Zhang, J Zhang, R Jin, Y Feng, B Su
Frontiers in immunology 2021
Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina
B Šušak, V Mikulić, A Lazarević, I Mikulić, J Arapovic
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2021
Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release
C Borchers, A Thyagarajan, CM Rapp, JB Travers, RP Sahu
Medical Sciences 2021
Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review
J Pérez-Galarza, C Prócel, C Cañadas, D Aguirre, R Pibaque, R Bedón, F Sempértegui, H Drexhage, L Baldeón
Human vaccines 2021
Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID‐19: A 6‐month follow‐up
S Yu, J An, X Liao, H Wang, F Ma, D Li, A Li, W Liu, S Zhang, M Liao, L Liu, J Zhao, S Xing, L Wei, Z Zhang
Clinical and Translational Medicine 2021
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
KW Ng, N Faulkner, AG Wrobel, SJ Gamblin, G Kassiotis
Seminars in Immunology 2021
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
M Dugas, T Grote-Westrick, U Merle, M Fontenay, AE Kremer, F Hanses, R Vollenberg, E Lorentzen, S Tiwari-Heckler, J Duchemin, S Ellouze, M Vetter, J Fürst, P Schuster, T Brix, CM Denkinger, C Müller-Tidow, H Schmidt, PR Tepasse, J Kühn
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2021
Immunity to SARS‐CoV‐2 induced by infection or vaccination
XC Dopico, S Ols, K Loré, GB Hedestam
Journal of Internal Medicine 2021
Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
Y Sui, Y Bekele, JA Berzofsky
Pathogens 2021
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
P Almendro-Vázquez, R Laguna-Goya, M Ruiz-Ruigomez, A Utrero-Rico, A Lalueza, G de la Calle, P Delgado, L Perez-Ordoño, E Muro, J Vila, I Zamarron, M Moreno-Batanero, M Chivite-Lacaba, F Gil-Etayo, C Martín-Higuera, M Meléndez-Carmona, C Lumbreras, I Arellano, B Alarcon, L Allende, J Aguado, E Paz-Artal, S Shresta
PLoS pathogens 2021
Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
X Tian, W Jiang, H Zhang, , L Li, W Liu, J Li
Frontiers in microbiology 2021
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
Abusukhun M, Winkler MS, Pöhlmann S, Moerer O, Meissner K, Tampe B, Hofmann-Winkler H, Bauer M, Gräler MH, Claus RA
Frontiers in immunology 2021
Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection.
Harrison SR, Klassen JRL, Bridgewood C, Scarsbrook A, Marzo-Ortega H, McGonagle D
Journal of Internal Medicine 2021
Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut
Papasavas P, Olugbile S, Wu U, Robinson K, Roberts AL, O'Sullivan DM, McLaughlin T, Mather JF, Steinberg AC, Orlando R, Kumar A
Journal of Hospital Infection 2021
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
Demonbreun AR, McDade TW, Pesce L, Vaught LA, Reiser NL, Bogdanovic E, Velez MP, Hsieh RR, Simons LM, Saber R, Ryan DT, Ison MG, Hultquist JF, Wilkins JT, D\u2019Aquila RT, Mustanski B, McNally EM
2021
Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests
Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa T, Takahashi S, Saito T, Misawa S, Akazawa C, Naito T, Miida T, Takahashi K, Ai T, Tabe Y
PloS one 2021
The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients
Tjan LH, Nagano T, Furukawa K, Nishimura M, Arii J, Fujinaka S, Iwata S, Sano S, Tohma Y, Nishimura Y, Mori Y
2021
Association of Viral Load in SARS-CoV-2 Patients With Age and Gender
Mahallawi WH, Alsamiri AD, Dabbour AF, Alsaeedi H, Al-Zalabani AH
Frontiers in Medicine 2021
Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels
Chen H, Qin R, Huang Z, He L, Luo W, Zheng P, Huang H, Wang H, Sun B
Frontiers in Molecular Biosciences 2021
COVID-19 re-infection: Diagnostic challenges and proposed diagnostic criteria
Raveendran AV
Diabetes & metabolic syndrome 2021
Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand
Putcharoen O, Wacharapluesadee S, Chia WN, Paitoonpong L, Tan CW, Suwanpimolkul G, Jantarabenjakul W, Ruchisrisarod C, Wanthong P, Sophonphan J, Chariyavilaskul P, Wang LF, Hemachudha T
PloS one 2021
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
Masiá M, Telenti G, Fernández M, García JA, Agulló V, Padilla S, García-Abellán J, Guillén L, Mascarell P, Asenjo JC, Gutiérrez F
Open Forum Infectious Diseases 2021
Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients
Ni L, Cheng ML, Feng Y, Zhao H, Liu J, Ye F, Ye Q, Zhu G, Li X, Wang P, Shao J, Deng YQ, Wei P, Chen F, Qin CF, Wang G, Li F, Zeng H, Dong C
Frontiers in immunology 2021
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
Zhou D, Chan JF, Zhou B, Zhou R, Li S, Shan S, Liu L, Zhang AJ, Chen SJ, Chan CC, Xu H, Poon VK, Yuan S, Li C, Chik KK, Chan CC, Cao J, Chan CY, Kwan KY, Du Z, Lau TT, Zhang Q, Zhou J, To KK, Zhang L, Ho DD, Yuen KY, Chen Z
Cell Host & Microbe 2021
Another front in COVID-19’s perfect storm
Jobe SM, Wen R
Blood 2021
Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection
Winkler MS, Claus RA, Schilder M, Pöhlmann S, Coldewey SM, Grundmann J, Fricke T, Moerer O, Meissner K, Bauer M, Hofmann-Winkler H, Gräler MH
Clinical science (London, England : 1979) 2021
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study
Rouphael N, Maecker H, Montgomery RR, Diray-Arce J, Kleinstein SH, Altman MC, Bosinger SE, Eckalbar W, Guan L, Hough CL, Krammer F, Langelier C, Levy O, McEnaney K, Peters B, Rahman A, Rajan JV, Sigelman S, Steen H, van Bakel H, Ward A, Wilson MR, Woodruff P, Zamecnik CR, Augustine AD, Ozonoff A, Reed EF, Becker PM, Higuita NA, Altman MC, Atkinson MA, Baden LR, Becker PM, Bime C, Brakenridge SC, Calfee CS, Cairns CB, Corry D, Davis MM, Augustine AD, Ehrlich LI, Haddad EK, Erle DJ, Fernandez-Sesma A, Hafler DA, Hough CL, Kheradmand F, Kleinstein SH, Kraft M, Levy O, McComsey GA, Melamed E, Messer W, Metcalf J, Montgomery RR, Nadeau KC, Ozonoff A, Peters B, Pulendran B, Reed EF, Rouphael N, Sarwal M, Schaenman J, Sekaly R, Shaw AC, Simon V
Science Immunology 2021
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N
2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CY, Lim JM, Kunasegaran K, Tan LW, Dutertre CA, Shankar N, Lim JM, Sun LJ, Zahari M, Tun ZM, Kumar V, Lim BL, Lim SH, Chia A, Tan YJ, Tambyah PA, Kalimuddin S, Lye D, Low JG, Wang LF, Wan WY, Hsu LY, Bertoletti A, Tam CC
Journal of Experimental Medicine 2021
Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS‐CoV‐2 spike protein
Horndler L, Delgado P, Abia D, Balabanov I, Martínez\u2010Fleta P, Cornish G, Llamas MA, Serrano\u2010Villar S, Sánchez\u2010Madrid F, Fresno M, van Santen HM, Alarcón B
EMBO Molecular Medicine 2021
Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic
Lentine KL, Mannon RB, Josephson MA
American Journal of Kidney Diseases 2021
Activated CD4+ T cells and CD14hiCD16+ monocytes correlate with antibody response following influenza virus infection in humans
Wong SS, Oshansky CM, Guo XZ, Ralston J, Wood T, Reynolds GE, Seeds R, Jelley L, Waite B, Jeevan T, Zanin M, Widdowson MA, Huang QS, Thomas PG, Webby RJ
Cell reports. Medicine 2021
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
Alshukairi AN, Zhao J, Al-Mozaini MA, Wang Y, Dada A, Baharoon SA, Alfaraj S, Ahmed WA, Enani MA, Elzein FE, Eltayeb N, Layqah L, El-Saed A, Bahaudden HA, Haseeb A, El-Kafrawy SA, Hassan AM, Siddiq NA, Alsharif I, Qushmaq I, Azhar EI, Perlman S, Memish ZA
Emerging infectious diseases 2021
Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons
Ibrahim EH, Alshahrani MY, Ghramh HA, Kilany M
Saudi Journal of Biological Sciences 2021
Salivette, a relevant saliva sampling device for SARS-CoV-2 detection
Melo Costa M, Benoit N, Dormoi J, Amalvict R, Gomez N, Tissot-Dupont H, Million M, Pradines B, Granjeaud S, Almeras L
Journal of Oral Microbiology 2021
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, DiBiase RM, Jia DT, Balabanov R, Ho SU, Batra A, Liotta EM, Koralnik IJ
Annals of Clinical and Translational Neurology 2021
Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice
Damluji AA, Christenson RH, deFilippi C
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2021
Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19
Amiya S, Hirata H, Shiroyama T, Adachi Y, Niitsu T, Noda Y, Enomoto T, Hara R, Fukushima K, Suga Y, Miyake K, Koide M, Uchiyama A, Takeda Y, Kumanogoh A
Respirology Case Reports 2021
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
Alharbi NK, Alghnam S, Algaissi A, Albalawi H, Alenazi MW, Albargawi AM, Alharbi AG, Alhazmi A, Al Qarni A, Alfarhan A, Zowawi HM, Alhatmi H, Alghamdi J, Alroqi F, Batarfi K, Arabi YM, Hashem AM, Bosaeed M, Aldibasi O
Journal of Infection and Public Health 2021
Potent and Persistent Antibody Response in COVID-19 Recovered Patients
Tian X, Liu L, Jiang W, Zhang H, Liu W, Li J
Frontiers in immunology 2021
Combined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 Patients in India
Chidananda MK, Zohmangaihi D, Ram S, Soni SL, Suri V, Malhotra P, Jassal RS, Kaur J, Verma I, Sharma S
Indian Journal of Clinical Biochemistry 2021
Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
Liao B, Chen Z, Zheng P, Li L, Zhuo J, Li F, Li S, Chen D, Wen C, Cai W, Wu S, Tang Y, Duan L, Wei P, Chen F, Yuan J, Yang J, Feng J, Zhao J, Zhao J, Sun B, Zhu A, Li Y, Tang X
Frontiers in immunology 2021
Methods to Identify Immunogenic Peptides in SARS‐CoV‐2 Spike and Protective Monoclonal Antibodies in COVID‐19 Patients
Li L, Gao M, Li J, Zu S, Wang Y, Chen C, Wan D, Duan J, Aliyari R, Wang J, Zhang J, Jin Y, Huang W, Jin X, Shi M, Wang Y, Qin C, Yang H, Cheng G
Small Methods 2021
Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges
Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK
Frontiers in microbiology 2021
Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID‐19: A case study
Karakaş Çelik S, Çakmak Genç G, Pişkin N, Açikgöz B, Altinsoy B, Kurucu İşsiz B, Dursun A
Journal of Medical Virology 2021
Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
Gomes LR, Durans AM, Napoleão-Pêgo P, Waterman JA, Freitas MS, De Sá NB, Pereira LV, Furtado JS, Aquino RG, Machado MC, Fintelman-Rodrigues N, Souza TM, Morel CM, Provance DW, De-Simone SG
Human vaccines 2021
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms
Vu DL, Martinez-Murillo P, Pigny F, Vono M, Meyer B, Eberhardt CS, Lemeille S, Von Dach E, Blanchard-Rohner G, Eckerle I, Huttner A, Siegrist CA, Kaiser L, Didierlaurent AM
Journal of Clinical Immunology 2021
Gut Microbiome Alterations in COVID-19
Zuo T, Wu X, Wen W, Lan P
Genomics, Proteomics & Bioinformatics 2021
Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
Cristiano A, Nuccetelli M, Pieri M, Sarubbi S, Pelagalli M, Calugi G, Tomassetti F, Bernardini S
International Immunopharmacology 2021
Longitudinal humoral antibody response to SARS-CoV-2 infection among healthcare workers in a New York City hospital
Menon V, Shariff MA, Perez Gutierrez V, Carreño JM, Yu B, Jawed M, Gossai M, Valdez E, Pillai A, Venugopal U, Kasubhai M, Dimitrov V, Krammer F
BMJ Open 2021
A renewable resource model of health decision-making: insights to improve health marketing
Lord Ferguson S, Berthon P
AMS Review 2021
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
Theel ES
Clinics in Laboratory Medicine 2021
Global Absence and Targeting of Protective Immune States in Severe COVID-19
Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Chew NW, Cleary SJ, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Im KW, Serwas NK, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S, Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF
Nature 2021
Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection
Shenoy S
Inflammation Research 2021
Quantitative Detection of Anti-SARS-CoV-2 Antibodies Using Indirect ELISA
Luo S, Xu J, Cho CY, Zhu S, Whittaker KC, Wang X, Feng J, Wang M, Xie S, Fang J, Huang AS, Song X, Huang RP
Laboratory Medicine 2021
Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
Blom KB, Åsberg A, Sjaastad I, Kalleberg KT, Søraas A, Midtvedt K, Birkeland JA
2021
Relative COVID-19 Viral Persistence and Antibody Kinetics.
Huang CG, Dutta A, Huang CT, Chang PY, Hsiao MJ, Hsieh YC, Lin SM, Shih SR, Tsao KC, Yang CT
2021
Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients
Li L, Tan C, Zeng J, Luo C, Hu S, Peng Y, Li W, Xie Z, Ling Y, Zhang X, Deng E, Xu H, Wang J, Xie Y, Zhou Y, Zhang W, Guo Y, Liu Z
Journal of Translational Medicine 2021
Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
Vaiserman A, Cuttler JM, Socol Y
Biogerontology 2021
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
dos Santos WG
Biomedicine & Pharmacotherapy 2021
Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19
Mustapha JO, Abdullahi IN, Ajagbe OO, Emeribe AU, Fasogbon SA, Onoja SO, Ugwu CE, Umeozuru CM, Ajayi FO, Tanko WN, Omosigho PO, Aliyu AS, Shuwa HA, Nwofe JO, Dangana A, Alaba O, Ghamba PE, Ibrahim Y, Aliyu D, Animasaun OS, Ugboaja NB, Baba Mallam MA, Abubakar SD, Aminu MS, Yahaya H, Oyewusi S
Heliyon 2021
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients
Yang HS, Racine-Brzostek SE, Karbaschi M, Yee J, Dillard A, Steel PA, Lee WT, McDonough KA, Qiu Y, Ketas TJ, Francomano E, Klasse PJ, Hatem L, Westblade L, Wu H, Chen H, Zuk R, Tan H, Girardin RC, Dupuis AP II, Payne AF, Moore JP, Cushing MM, Chadburn A, Zhao Z
Biosensors & bioelectronics 2021
Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients
Serre-Miranda C, Nobrega C, Roque S, Canto-Gomes J, Silva CS, Vieira N, Barreira-Silva P, Alves-Peixoto P, Cotter J, Reis A, Formigo M, Sarmento H, Pires O, Carvalho A, Petrovykh DY, Diéguez L, Sousa JC, Sousa N, Capela C, Palha JA, Cunha PG, Correia-Neves M
International Journal of Infectious Diseases 2021
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
O\u2019Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM
2021
Immune responses and therapeutic challenges in paediatric patients with new‐onset acute myeloid leukaemia and concomitant COVID‐19
Patel PA, Lapp SA, Grubbs G, Edara VV, Rostad CA, Stokes CL, Pauly MG, Anderson EJ, Piantadosi A, Suthar MS, Khurana S, Sabnis HS
British Journal of Haematology 2021
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Xiang T, Liang B, Fang Y, Lu S, Li S, Wang H, Li H, Yang X, Shen S, Zhu B, Wang B, Wu J, Liu J, Lu M, Yang D, Dittmer U, Trilling M, Deng F, Zheng X
Frontiers in immunology 2021
COVID-19 Repeated Convalescent Plasma Collection: Analysis of 149 Donations from 88 French Military Health Workers
Conan PL, Ficko C, Chueca M, Rolland C, Javaudin O, Bigaillon C, Durand GA, Leparc-Goffart I, Verret C, Aletti M, Dutasta F, Savini H, Bosson JL, Martinaud C
Transfusion Medicine and Hemotherapy 2021
Development of a novel, pan-variant aerosol intervention for COVID-19
Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G
2021
Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers
Kurano M, Morita Y, Nakano Y, Yokoyama R, Shimura T, Qian C, Xia F, He F, Zheng L, Ohmiya H, Kishi Y, Okada J, Yoshikawa N, Nakajima K, Nagura Y, Okazaki H, Jubishi D, Moriya K, Seto Y, Yasui F, Kohara M, Wakui M, Kawamura T, Kodama T, Yatomi Y
International Immunopharmacology 2021
Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization
Fumagalli MJ, Castro-Jorge LA, Fraga-Silva TF, de Azevedo PO, Capato CF, Rattis BA, Hojo-Souza NS, Floriano VG, de Castro JT, Ramos SG, da Fonseca BA, Bonato VL, Gazzinelli RT, Figueiredo LT
Viruses 2021
Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
Guerrieri M, Francavilla B, Fiorelli D, Nuccetelli M, Passali FM, Coppeta L, Somma G, Bernardini S, Magrini A, Di Girolamo S
Human vaccines 2021
SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort
Molenaar NM, Rommel AS, de Witte L, Dolan SM, Lieb W, Ibroci E, Ohrn S, Lynch J, Capuano C, Stadlbauer D, Krammer F, Zapata LB, Brody RI, Pop VJ, Jessel RH, Sperling RS, Afzal O, Gigase F, Missall R, Janevic T, Stone J, Howell EA, Bergink V
Paediatric and Perinatal Epidemiology 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
Tan AT, Linster M, Tan CW, Le Bert N, Chia WN, Kunasegaran K, Zhuang Y, Tham CYL, Chia A, Smith GJD, Young B, Kalimuddin S, Low JGH, Lye D, Wang LF, Bertoletti A
Cell Reports 2021
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
Borgonovo F, Passerini M, Piscaglia M, Morena V, Giacomelli A, Oreni L, Dedivitiis G, Lupo A, Falvella S, Cossu MV, Capetti AF
Journal of Infection 2021
Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
Shrotri M, Harris RJ, Rodger A, Planche T, Sanderson F, Mahungu T, McGregor A, Heath PT, Brown CS, Dunning J, Hopkins S, Ladhani S, Chand M
Emerging infectious diseases 2021
Antibody kinetics and clinical course of COVID-19 a prospective observational study.
Bläckberg A, Fernström N, Sarbrant E, Rasmussen M, Sunnerhagen T
PloS one 2021
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic.
Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee CK, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C
Vox Sanguinis 2021
Trends of COVID-19 Admissions in an Italian Hub during the Pandemic Peak: Large Retrospective Study Focused on Older Subjects.
Ticinesi A, Nouvenne A, Cerundolo N, Parise A, Prati B, Guerra A, Meschi T
Journal of Clinical Medicine 2021
Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans.
Yang S, Jerome KR, Greninger AL, Schiffer JT, Goyal A
Viruses 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.
Kaplonek P, Wang C, Bartsch Y, Fischinger S, Gorman MJ, Bowman K, Kang J, Dayal D, Martin P, Nowak RP, Villani AC, Hsieh CL, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Sade-Feldman M, Feldman J, Julg B, Nilles EJ, Musk ER, Menon AS, Fischer ES, McLellan JS, Schmidt A, Goldberg MB, Filbin MR, Hacohen N, Lauffenburger DA, Alter G
Science Immunology 2021
Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
Lustig Y, Cohen C, Biber A, Jaber H, Becker Ilany Y, Indenbaum V, Amit S, Mandelboim M, Mendelson E, Regev-Yochay G
Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 2021
Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.
Charilaou P, Tricarico C, Battat R, Scherl EJ, Longman RS, Lukin DJ
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021
The relationship between COVID-19 viral load and disease severity: A systematic review.
Dadras O, Afsahi AM, Pashaei Z, Mojdeganlou H, Karimi A, Habibi P, Barzegary A, Fakhfouri A, Mirzapour P, Janfaza N, Dehghani S, Afroughi F, Dashti M, Khodaei S, Mehraeen E, Voltarelli F, Sabatier JM, SeyedAlinaghi S
Immunity, Inflammation and Disease 2021
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19.
Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ
Future Virology 2021
Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study
Adachi Y, Shiroyama T, Yamaguchi Y, Murakami T, Hirata H, Amiya S, Niitsu T, Noda Y, Hara R, Enomoto T, Morita T, Kato Y, Uchiyama A, Takeda Y, Kumanogoh A
Journal of Infection 2021
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
Trinité B, Tarrés-Freixas F, Rodon J, Pradenas E, Urrea V, Marfil S, Rodríguez de la Concepción ML, Ávila-Nieto C, Aguilar-Gurrieri C, Barajas A, Ortiz R, Paredes R, Mateu L, Valencia A, Guallar V, Ruiz L, Grau E, Massanella M, Puig J, Chamorro A, Izquierdo-Useros N, Segalés J, Clotet B, Carrillo J, Vergara-Alert J, Blanco J
Scientific Reports 2021
Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs
Stoddard CI, Galloway J, Chu HY, Shipley MM, Sung K, Itell HL, Wolf CR, Logue JK, Magedson A, Garrett ME, Crawford KH, Laserson U, Matsen FA IV, Overbaugh J
Cell Reports 2021
Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis
Aubry A, Demey B, François C, Duverlie G, Castelain S, Helle F, Brochot E
Journal of Clinical Medicine 2021
Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study
Xu X, Nie S, Wang Y, Long Q, Zhu H, Zhang X, Sun J, Zeng Q, Zhao J, Liu L, Li L, Huang A, Hou J, Hou FF
Signal Transduction and Targeted Therapy 2021
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
Kaplonek P, Wang C, Bartsch Y, Fischinger S, Gorman MJ, Bowman K, Kang J, Dayal D, Martin P, Nowak R, Hsieh CL, Feldman J, Julg B, Nilles EJ, Musk ER, Menon AS, Fischer ES, McLellan JS, Schmidt A, Goldberg MB, Filbin M, Hacohen N, Lauffenburger DA, Alter G
2021
Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?
Beams AB, Bateman R, Adler FR
Viruses 2021
Developing a Paper-Based Antigen Assay to Differentiate between Coronaviruses and SARS-CoV-2 Spike Variants
Hristov D, Rijal H, Gomez-Marquez J, Hamad-Schifferli K
Analytical Chemistry 2021
Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers
Scurr MJ, Zelek WM, Lippiatt G, Somerville M, Burnell SE, Capitani L, Davies K, Lawton H, Tozer T, Rees T, Roberts K, Evans M, Jackson A, Young C, Fairclough L, Tighe P, Wills M, Westwell AD, Morgan BP, Gallimore A, Godkin A
Immunology 2021
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID‐19 infection: Prospective observational study
Yalçın TY, Topçu Dİ, Doğan Ö, Aydın S, Sarı N, Erol Ç, Kuloğlu ZE, Azap ÖK, Can F, Arslan H
Journal of Medical Virology 2021
Ribavirin Treatment for Critically Ill COVID-19 Patients: An Observational Study
Xu Y, Li M, Zhou L, Liu D, He W, Liang W, Sun Q, Sun H, Li Y, Liu X
Infection and drug resistance 2021
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
Yang L, Xu Q, Yang B, Li J, Dong R, Da J, Ye Z, Xu Y, Zhou H, Zhang X, Liu L, Zha Y, Yu F
BMC Microbiology 2021
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
Mellinghoff SC, Vanshylla K, Dahlke C, Addo MM, Cornely OA, Klein F, Persigehl T, Rybniker J, Gruell H, Bröckelmann PJ
Frontiers in immunology 2021
Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia
Alosaimi MF, Alhetheel A, Aleisa KA, Altwerki AA, Alenezy NM, Almutairi EM, Alothaim LO, Khalid AM, Alayed KM, Almazyad MA, BinMoammar TA, Alshobaili FA, Al-Shahrani FS, Alsubaie S, Hasanato RM
Saudi Medical Journal 2021
Neutralizing antibody titres in SARS-CoV-2 infections.
Lau EHY, Tsang OTY, Hui DSC, Kwan MYW, Chan WH, Chiu SS, Ko RLW, Chan KH, Cheng SMS, Perera RAPM, Cowling BJ, Poon LLM, Peiris M
Nature Communications 2021
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A, Torres I, Latorre V, Francés-Gómez C, Albert E, Gozalbo-Rovira R, Alcaraz MJ, Buesa J, Rodríguez-Díaz J, Geller R, Navarro D
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2021
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
Takeshita M, Nishina N, Moriyama S, Takahashi Y, Uwamino Y, Nagata M, Aoki W, Masaki K, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K, Fukunaga K, Takeuchi T
Virology 2021
Longitudinal Serology of SARS-CoV-2-Infected Individuals in India: A Prospective Cohort Study.
Thiruvengadam R, Chattopadhyay S, Mehdi F, Desiraju BK, Chaudhuri S, Singh S, Bhartia V, Kshetrapal P, Mouli Natchu UC, Wadhwa N, Sopory S, Wahi M, Pandey AK, Taneja J, Anand N, Sharma N, Sharma P, Saxena S, Sindhu D, Sindhu B, Sharma D, Shrivastava T, Dang A, Batra G, Kang G, Bhatnagar S
The American journal of tropical medicine and hygiene 2021
Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study.
Zhao L, Gao R, Lu R, Wang H, Deng Y, Niu P, Jiang F, Huang B, Liang J, Jia J, Zhang F, Wang W, Wu G, Tan W
Virologica Sinica 2021
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.
Marchi S, Viviani S, Remarque EJ, Ruello A, Bombardieri E, Bollati V, Milani GP, Manenti A, Lapini G, Rebuffat A, Montomoli E, Trombetta CM
PloS one 2021
Insights into the virologic and immunologic features of SARS-COV-2.
Polat C, Ergunay K
World journal of clinical cases 2021
Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
Mrzljak A, Jureković Ž, Pavičić-Šarić J, Stevanović V, Tabain I, Hruškar Ž, Mikulić D, Barbić L, Vilibić-Čavlek T
Biochemia Medica 2021
SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review
Shenoy S
World Journal of Critical Care Medicine 2021
A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein
Vernet R, Charrier E, Grogg J, Mach N
Human vaccines 2021
Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan
Imai K, Kitagawa Y, Tabata S, Kubota K, Nagura\u2010Ikeda M, Matsuoka M, Miyoshi K, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Ito T, Maesaki S, Tamura K, Maeda T
Journal of Medical Virology 2021
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia
Alhabbab RY, Alsaieedi A, Algaissi A, Almahboub S, Al-Raddadi RM, Shabouni OI, Alhabbab R, Alfaraj AA, Alamri SS, Aljehani ND, Abdulal RH, Alfaleh MA, Abujamel TS, Alkayyal AA, Mahmoud AB, Abuzenadah AM, Hashem AM
Viruses 2021
Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
Riester E, Majchrzak M, Mühlbacher A, Tinguely C, Findeisen P, Hegel JK, Laimighofer M, Rank CM, Schönfeld K, Langen F, Laengin T, Niederhauser C
Infectious Diseases and Therapy 2021
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses
Gozlan Y, Reingold S, Koren R, Halpern O, Regev-Yochay G, Cohen C, Biber A, Picard O, Mendelson E, Lustig Y, Mor O
Epidemiology and Infection 2021
Efficient COVID-19 testing via contextual model based compressive sensing
Hasaninasab M, Khansari M
Pattern Recognition 2021
Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities
Imai K, Matsuoka M, Tabata S, Kitagawa Y, Nagura-Ikeda M, Kubota K, Fukada A, Takada T, Sato M, Noguchi S, Takeuchi S, Arakawa N, Miyoshi K, Saito Y, Maeda T
International Journal of Infectious Diseases 2021
Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
Bonetti TC, Latini FR, Invitti AL, Fonseca MC, Scorza FA, Saldanha MG, Bellucco FT, Bacarov NB, Soane MM, Girão MJ
Clinics 2021
Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July–August 2020: a mail-based cross-sectional study
Snyder T, Ravenhurst J, Cramer EY, Reich NG, Balzer L, Alfandari D, Lover AA
BMJ Open 2021
The Impact of SARS-CoV-2 Viral Load on the Mortality of Hospitalized Patients: A Retrospective Analysis
Machado A, Salvador P, Oliveira P, Teixeira T, Figueiredo C, Nunes S, Silva L, Silva L, Costa T, Malheiro L
Cureus 2021
Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
Riester E, Findeisen P, Hegel JK, Kabesch M, Ambrosch A, Rank CM, Pessl F, Laengin T, Niederhauser C
Journal of Virological Methods 2021
Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
Thümmler L, Schwarzkopf S, Knop D, Ross JA, Berg V, Horn PA, Lindemann M
Diagnostics 2021
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
Casadevall A, Joyner MJ, Pirofski LA
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021
Blockade of SARS-CoV-2 spike protein-mediated cell-cell fusion using COVID-19 convalescent plasma.
Wang L, Zhao J, Nguyen LNT, Adkins JL, Schank M, Khanal S, Nguyen LN, Dang X, Cao D, Thakuri BKC, Lu Z, Zhang J, Zhang Y, Wu XY, El Gazzar M, Ning S, Moorman JP, Yao ZQ
Scientific Reports 2021
Mouth Washing Impaired SARS-CoV-2 Detection in Saliva
Costa MM, Benoit N, Tissot-Dupont H, Million M, Pradines B, Granjeaud S, Almeras L
Diagnostics 2021
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Bertoletti A, Tan AT, Le Bert N
2021
Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study
Snyder T, Ravenhurst J, Cramer EY, Reich NG, Balzer LB, Alfandari D, Lover AA
2021
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski
Journal of Clinical Investigation 2020
Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Fang Gong, Yaping Dai, Ting Zheng, Liang Cheng, Dan Zhao, Hao Wang, Min Liu, Hao Pei, Tengchuan Jin, Di Yu, Pengcheng Zhou
Journal of Clinical Investigation 2020
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors
Cong Zeng, John P. Evans, Rebecca Pearson, Panke Qu, Yi-Min Zheng, Richard T. Robinson, Luanne Hall-Stoodley, Jacob S. Yount, Sonal Pannu, Rama K. Mallampalli, Linda Saif, Eugene Oltz, Gerard Lozanski, Shan-Lu Liu
JCI Insight 2020
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar
International Immunopharmacology 2020
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois
Frontiers in immunology 2020
Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2
KD McCormick, JW Mellors, JL Jacobs
Current Opinion in HIV and AIDS 2020
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, KA Alluhaybi, HI Hobani, RM Alsulaiman, RH AlHarbi, MZ ElAssouli, RY Alhabbab, AA AlSaieedi, WH Abdulaal, AA Al-Somali, FS Alofi, AA Khogeer, AA Alkayyal, AB Mahmoud, NA Almontashiri, A Pain, AM Hashem
Scientific Reports 2020
Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients
Ko JH, Joo EJ, Park SJ, Baek JY, Kim WD, Jee J, Kim CJ, Jeong C, Kim YJ, Shon HJ, Kang ES, Choi YK, Peck KR
Journal of Clinical Medicine 2020
Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies
Guo X, Zeng L, Huang Z, He Y, Zhang Z, Zhong Z
Frontiers in immunology 2020
Old friends meet a new foe: A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality
Cepon-Robins TJ, Gildner TE
Evolution, Medicine, and Public Health 2020
SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality
Bryan A, Fink SL, Gattuso MA, Pepper G, Chaudhary A, Wener MH, Morishima C, Jerome KR, Mathias PC, Greninger AL
Open Forum Infectious Diseases 2020
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
Indenbaum V, Koren R, Katz-Likvornik S, Yitzchaki M, Halpern O, Regev-Yochay G, Cohen C, Biber A, Feferman T, Cohen Saban N, Dhan R, Levin T, Gozlan Y, Weil M, Mor O, Mandelboim M, Sofer D, Mendelson E, Lustig Y
PloS one 2020
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi R, Jan AT, Rahman S, Kim J
Frontiers in Cellular and Infection Microbiology 2020
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature
Fontana LM, Villamagna AH, Sikka MK, McGregor JC
Infection Control and Hospital Epidemiology 2020
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Liu Z, Xu W, Xia S, Gu C, Wang X, Wang Q, Zhou J, Wu Y, Cai X, Qu D, Ying T, Xie Y, Lu L, Yuan Z, Jiang S
Signal Transduction and Targeted Therapy 2020
Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses
Kwon JS, Kim JY, Kim MC, Park SY, Kim BN, Bae S, Cha HH, Jung J, Kim MJ, Lee MJ, Choi SH, Chung JW, Shin EC, Kim SH
The American journal of tropical medicine and hygiene 2020
Dosing Considerations for Antibodies Against COVID-19
Tegenge MA, Mahmood I, Struble E, Golding B
Drugs in R & D 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Röltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, Hunter M, Wang H, Sahoo MK, Huang C, Yamamoto F, Manohar M, Manalac J, Otrelo-Cardoso AR, Pham TD, Rustagi A, Rogers AJ, Shah NH, Blish CA, Cochran JR, Jardetzky TS, Zehnder JL, Wang TT, Narasimhan B, Gombar S, Tibshirani R, Nadeau KC, Kim PS, Pinsky BA, Boyd SD
Science Immunology 2020
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
Saad-Roy CM, Wagner CE, Baker RE, Morris SE, Farrar J, Graham AL, Levin SA, Mina MJ, Metcalf CJ, Grenfell BT
Science (New York, N.Y.) 2020
Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics
Colavita F, Lapa D, Carletti F, Lalle E, Messina F, Rueca M, Matusali G, Meschi S, Bordi L, Marsella P, Nicastri E, Marchioni L, Mariano A, Scorzolini L, Ascoli Bartoli T, Di Caro A, Ippolito G, Capobianchi MR, Castilletti C
Open Forum Infectious Diseases 2020
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Jiang C, Wang Y, Hu M, Wen L, Wen C, Wang Y, Zhu W, Tai S, Jiang Z, Xiao K, Faria NR, De Clercq E, Xu J, Li G
IBMS BoneKEy 2020
Intermittent viral shedding in respiratory samples of patients with SARS-CoV-2: observational analysis with infection control implications
AlJishi JM, Al-Tawfiq JA
Journal of Hospital Infection 2020
Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype
Habel JR, Nguyen TH, van de Sandt CE, Juno JA, Chaurasia P, Wragg K, Koutsakos M, Hensen L, Jia X, Chua B, Zhang W, Tan HX, Flanagan KL, Doolan DL, Torresi J, Chen W, Wakim LM, Cheng AC, Doherty PC, Petersen J, Rossjohn J, Wheatley AK, Kent SJ, Rowntree LC, Kedzierska K
Proceedings of the National Academy of Sciences 2020
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Young MK, Kornmeier C, Carpenter RM, Natale NR, Sasson JM, Solga MD, Mathers AJ, Poulter MD, Qiang X, Petri WA Jr
2020
COVID-19 update: the first 6 months of the pandemic
Novelli G, Biancolella M, Mehrian-Shai R, Erickson C, Godri Pollitt KJ, Vasiliou V, Watt J, Reichardt JK
Human genomics 2020
Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Wang K, Long QX, Deng HJ, Hu J, Gao QZ, Zhang GJ, He CL, Huang LY, Hu JL, Chen J, Tang N, Huang AL
Clinical Infectious Diseases 2020
A Retrospective Analysis and Comparison of Prisoners and Community-Based Patients with COVID-19 Requiring Intensive Care During the First Phase of the Pandemic in West Texas
Ali K, Rao S, Berdine G, Test V, Nugent K
Journal of Primary Care & Community Health 2020
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
Gozalbo-Rovira R, Gimenez E, Latorre V, Francés-Gómez C, Albert E, Buesa J, Marina A, Blasco ML, Signes-Costa J, Rodríguez-Díaz J, Geller R, Navarro D
Journal of Clinical Virology 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19.
Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Cleary SJ, Chew NW, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S, Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF
Research square 2020
Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model
Zhang Z, Zhang L, Zhu A, Wang Y, Guan W, Zeng Z, Sun J, Li F, Zhao J, Yang Z, Zhao J, Zhong N
Journal of Thoracic Disease 2020
Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS
The Journal of Infectious Diseases 2020
Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities
Chiara M, D\u2019Erchia AM, Gissi C, Manzari C, Parisi A, Resta N, Zambelli F, Picardi E, Pavesi G, Horner DS, Pesole G
Briefings in Bioinformatics 2020
SARS-COV-2 IgG antibody response in pregnant women at delivery.
Tsatsaris V, Mariaggi AA, Launay O, Couffignal C, Rousseau J, Ancel PY, Marcault E, Ville Y, Cordier AG, Vivanti A, Carrara J, Luton D, Dommergues M, Borie C, Kayem G, Alessandrini V, Lecomte L, Meritet JF, Leruez-Ville M, Goffinet F, Dubois C, Picone O, Vauloup Fellous C
Journal of Gynecology Obstetrics and Human Reproduction 2020
The kinetics of viral load and antibodies to SARS-CoV-2
Sun J, Tang X, Bai R, Liang C, Zeng L, Lin H, Yuan R, Zhou P, Huang X, Xiong Q, Peng J, Cui F, Ke B, Su J, Liu Z, Lu J, Tian J, Sun R, Ke C
Clinical Microbiology and Infection 2020
First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform
Stieber F, Howard J, Rao SN, Kawamura LM, Manissero D, Love J, Yang M, Uchiyama R, Parsons S, Miller C, Douwes H, McDonald A, Fairburn L, Boyle J
Journal of Clinical Virology 2020
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
Ishigaki H, Nakayama M, Kitagawa Y, Nguyen CT, Hayashi K, Shiohara M, Gotoh B, Itoh Y
Virology 2020
Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.
Karatza E, Ismailos G, Marangos M, Karalis V
Xenobiotica; the fate of foreign compounds in biological systems 2020
Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test.
Young S, Taylor SN, Cammarata CL, Varnado KG, Roger-Dalbert C, Montano A, Griego-Fullbright C, Burgard C, Fernandez C, Eckert K, Andrews JC, Ren H, Allen J, Ackerman R, Cooper CK
Journal of clinical microbiology 2020
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC.
Yoon HA, Bartash R, Gendlina I, Rivera J, Nakouzi A, Bortz RH 3rd, Wirchnianski AS, Paroder M, Fehn K, Serrano-Rahman L, Babb R, Sarwar UN, Haslwanter D, Laudermilch E, Florez C, Dieterle ME, Jangra RK, Fels JM, Tong K, Mariano MC, Vergnolle O, Georgiev GI, Herrera NG, Malonis RJ, Quiroz JA, Morano NC, Krause GJ, Sweeney JM, Cowman K, Allen S, Annam J, Applebaum A, Barboto D, Khokhar A, Lally BJ, Lee A, Lee M, Malaviya A, Sample R, Yang XA, Li Y, Ruiz R, Thota R, Barnhill J, Goldstein DY, Uehlinger J, Garforth SJ, Almo SC, Lai JR, Gil MR, Fox AS, Chandran K, Wang T, Daily JP, Pirofski LA
medRxiv : the preprint server for health sciences 2020
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Natarajan H, Crowley AR, Butler SE, Xu S, Weiner JA, Bloch EM, Littlefield K, Wieland-Alter W, Connor RI, Wright PF, Benner SE, Bonny TS, Laeyendecker O, Sullivan D, Shoham S, Quinn TC, Larman HB, Casadevall A, Pekosz A, Redd AD, Tobian AA, Ackerman ME
2020
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
Morgenlander W, Henson S, Monaco D, Chen A, Littlefield K, Bloch EM, Fujimura E, Ruczinski I, Crowley AR, Natarajan H, Butler SE, Weiner JA, Li MZ, Bonny TS, Benner SE, Ashwin Balagopal, Sullivan D, Shoham S, Quinn TC, Eshleman S, Casadevall A, Redd AD, Laeyendecker O, Ackerman ME, Pekosz A, Elledge SJ, Robinson M, Tobian AA, Larman HB
2020

← Previous 1 2 3 … 15 16 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 27 news outlets
Referenced in 1 policy sources
Posted by 41 X users
On 2 Facebook pages
525 readers on Mendeley
See more details